Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Navigation/Suche

• Forscher*innen.
  • Curriculum.
  • Publikationen.
  • Projekte.
  • Präsentationen.
  • Betreute Dipl u. Diss.
• Institutionen.
• Projekte.
• Publikationen.
• Partner.
• Geldgeber.
• Ausstattung.
• Knowhow.
• Forschungsfelder.

Khalil Michael |

** = Publikationen gelistet in SCI/SSCI/Pubmed

2023

Originalarbeit (Zeitschrift)

** Buchmann, A; Pirpamer, L; Pinter, D; Voortman, M; Helmlinger, B; Pichler, A; Maceski, AM; Benkert, P; Bachmaier, G; Ropele, S; Reindl, M; Leppert, D; Kuhle, J; Enzinger, C; Khalil, M High serum neurofilament light chain levels correlate with brain atrophy and physical disability in multiple sclerosis.
Eur J Neurol. 2023; Doi: 10.1111/ene.15742
PubMed FullText FullText_MUG

 

** Callegari, I; Schneider, M; Aebischer, V; Voortman, MM; Proschmann, U; Ziemssen, T; Lindberg, R; Fischer-Barnicol, B; Khalil, M; Kappos, L; Kuhle, J; Sanderson, NSR; Derfuss, T Natalizumab in cerebrospinal fluid and breastmilk of patients with multiple sclerosis.
Ther Adv Neurol Disord. 2023; 16: 17562864221150040 Doi: 10.1177/17562864221150040 [OPEN ACCESS]
PubMed FullText FullText_MUG

 

** Gattringer, T; Enzinger, C; Pinter, D; Fandler-Höfler, S; Kneihsl, M; Haidegger, M; Eppinger, S; Demjaha, R; Buchmann, A; Jerkovic, A; Schmidt, R; Khalil, M Serum glial fibrillary acidic protein is sensitive to acute but not chronic tissue damage in cerebral small vessel disease.
J Neurol. 2023; 270(1):320-327 Doi: 10.1007/s00415-022-11358-7 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Hegen, H; Arrambide, G; Gnanapavan, S; Kaplan, B; Khalil, M; Saadeh, R; Teunissen, C; Tumani, H; Villar, LM; Willrich, MAV; Zetterberg, H; Deisenhammer, F Cerebrospinal fluid kappa free light chains for the diagnosis of multiple sclerosis: A consensus statement.
Mult Scler. 2023; 29(2):182-195 Doi: 10.1177/13524585221134217 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Hegen, H; Walde, J; Berek, K; Arrambide, G; Gnanapavan, S; Kaplan, B; Khalil, M; Saadeh, R; Teunissen, C; Tumani, H; Villar, LM; Willrich, MAV; Zetterberg, H; Deisenhammer, F Cerebrospinal fluid kappa free light chains for the diagnosis of multiple sclerosis: A systematic review and meta-analysis.
Mult Scler. 2022; 13524585221134213 Doi: 10.1177/13524585221134213 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Herrera-Rivero, M; Hofer, E; Maceski, A; Leppert, D; Benkert, P; Kuhle, J; Schmidt, R; Khalil, M; Wiendl, H; Stoll, M; Berger, K Evidence of polygenic regulation of the physiological presence of neurofilament light chain in human serum.
Front Neurol. 2023; 14:1145737 Doi: 10.3389/fneur.2023.1145737 [OPEN ACCESS]
PubMed FullText FullText_MUG

 

** Hodl, I; Sallegger, C; Forstner, P; Sareban, N; Moritz, M; Dreo, B; Schulz, E; Lackner, A; Kleinhappl, B; Hatzl, S; Moazedi-Fürst, F; Seifert-Held, T; Heschl, B; Khalil, M; Enzinger, C; Greinix, H; Stradner, MH; Steinmetz, I; Schlenke, P; Fessler, J Altered cellular immune response to vaccination against SARS-CoV-2 in patients suffering from autoimmunity with B-cell depleting therapy.
Microbes Infect. 2023; 105103 Doi: 10.1016/j.micinf.2023.105103 [OPEN ACCESS]
PubMed FullText FullText_MUG

 

** Meier, S; Willemse, EAJ; Schaedelin, S; Oechtering, J; Lorscheider, J; Melie-Garcia, L; Cagol, A; Barakovic, M; Galbusera, R; Subramaniam, S; Barro, C; Abdelhak, A; Thebault, S; Achtnichts, L; Lalive, P; Müller, S; Pot, C; Salmen, A; Disanto, G; Zecca, C; D'Souza, M; Orleth, A; Khalil, M; Buchmann, A; Du, Pasquier, R; Yaldizli, Ö; Derfuss, T; Berger, K; Hermesdorf, M; Wiendl, H; Piehl, F; Battaglini, M; Fischer, U; Kappos, L; Gobbi, C; Granziera, C; Bridel, C; Leppert, D; Maleska, Maceski, A; Benkert, P; Kuhle, J Serum Glial Fibrillary Acidic Protein Compared With Neurofilament Light Chain as a Biomarker for Disease Progression in Multiple Sclerosis.
JAMA Neurol. 2023; 80(3):287-97 Doi: 10.1001/jamaneurol.2022.5250 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Seiberl, M; Feige, J; Hilpold, P; Hitzl, W; Machegger, L; Buchmann, A; Khalil, M; Trinka, E; Harrer, A; Wipfler, P; Moser, T Serum Neurofilament Light Chain as Biomarker for Cladribine-Treated Multiple Sclerosis Patients in a Real-World Setting.
Int J Mol Sci. 2023; 24(4): Doi: 10.3390/ijms24044067 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2022

Originalarbeit (Zeitschrift)

** Abdelrahman, A; Negroni, C; Sahm, F; Adams, CL; Urbanic-Purkart, T; Khalil, M; Vergura, R; Morelli, C; Hanemann, CO miR-497 and 219 in blood aid meningioma classification
J NEURO-ONCOL. 2022; Doi: 10.1007/s11060-022-04126-0
Web of Science PubMed FullText FullText_MUG

 

** Benkert, P; Meier, S; Schaedelin, S; Manouchehrinia, A; Yaldizli, Ö; Maceski, A; Oechtering, J; Achtnichts, L; Conen, D; Derfuss, T; Lalive, PH; Mueller, C; Müller, S; Naegelin, Y; Oksenberg, JR; Pot, C; Salmen, A; Willemse, E; Kockum, I; Blennow, K; Zetterberg, H; Gobbi, C; Kappos, L; Wiendl, H; Berger, K; Sormani, MP; Granziera, C; Piehl, F; Leppert, D; Kuhle, J, , NfL, Reference, Database, in, the, Swiss, Multiple, Sclerosis, Cohort, Study, Group Serum neurofilament light chain for individual prognostication of disease activity in people with multiple sclerosis: a retrospective modelling and validation study.
Lancet Neurol. 2022; 21(3): 246-257. Doi: 10.1016/S1474-4422(22)00009-6
Web of Science PubMed FullText FullText_MUG

 

** Filippi, M; Preziosa, P; Meani, A; Dalla, Costa, G; Mesaros, S; Drulovic, J; Ivanovic, J; Rovira, A; Tintorè, M; Montalban, X; Ciccarelli, O; Brownlee, W; Miszkiel, K; Enzinger, C; Khalil, M; Barkhof, F; Strijbis, EMM; Frederiksen, JL; Cramer, SP; Fainardi, E; Amato, MP; Gasperini, C; Ruggieri, S; Martinelli, V; Comi, G; Rocca, MA, , MAGNIMS, Study, Group Performance of the 2017 and 2010 Revised McDonald Criteria in Predicting MS Diagnosis After a Clinically Isolated Syndrome: A MAGNIMS Study.
Neurology. 2022; 98(1):e1-e14 Doi: 10.1212/WNL.0000000000013016
Web of Science PubMed FullText FullText_MUG

 

** Hechenberger, S; Helmlinger, B; Ropele, S; Pirpamer, L; Bachmaier, G; Damulina, A; Pichler, A; Khalil, M; Enzinger, C; Pinter, D Information processing speed as a prognostic marker of physical impairment and progression in patients with multiple sclerosis.
Mult Scler Relat Disord. 2022; 57: 103353 Doi: 10.1016/j.msard.2021.103353
Web of Science PubMed FullText FullText_MUG

 

** Jarius, S; Pache, F; Körtvelyessy, P; Jelčić, I; Stettner, M; Franciotta, D; Keller, E; Neumann, B; Ringelstein, M; Senel, M; Regeniter, A; Kalantzis, R; Willms, JF; Berthele, A; Busch, M; Capobianco, M; Eisele, A; Reichen, I; Dersch, R; Rauer, S; Sandner, K; Ayzenberg, I; Gross, CC; Hegen, H; Khalil, M; Kleiter, I; Lenhard, T; Haas, J; Aktas, O; Angstwurm, K; Kleinschnitz, C; Lewerenz, J; Tumani, H; Paul, F; Stangel, M; Ruprecht, K; Wildemann, B, , ; in, cooperation, with, the, German, Society, for, Cerebrospinal, Fluid, Diagnostics, and, Clinical, Neurochemistry Cerebrospinal fluid findings in COVID-19: a multicenter study of 150 lumbar punctures in 127 patients.
J Neuroinflammation. 2022; 19(1): 19 Doi: 10.1186/s12974-021-02339-0 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Kern, D; Khalil, M; Pirpamer, L; Buchmann, A; Hofer, E; Dal-Bianco, P; Stögmann, E; Scherfler, C; Benke, T; Ransmayr, G; Schmidt, R Serum NfL in Alzheimer Dementia: Results of the Prospective Dementia Registry Austria.
Medicina (Kaunas). 2022; 58(3): Doi: 10.3390/medicina58030433 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Magyar, M; Gattringer, T; Enzinger, C; Hassler, E; Partl, R; Khalil, M; Reishofer, G; Deutschmann, H; Fazekas, F Incidence of Developmental Venous Anomalies in Patients With Multiple Sclerosis: A 3 Tesla MRI Study.
Front Neurol. 2022; 13: 824347 Doi: 10.3389/fneur.2022.824347 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Oechtering, J; Lincke, T; Schaedelin, S; Décard, BF; Maceski, A; Orleth, A; Meier, S; Willemse, E; Buchmann, A; Khalil, M; Derfuss, T; Benkert, P; Heijnen, I; Regeniter, A; Müller, S; Achtnichts, L; Lalive, P; Salmen, A; Pot, C; Gobbi, C; Kappos, L; Granziera, C; Leppert, D; Schlaeger, R; Lieb, JM; Kuhle, J, , Swiss, MS, Cohort, Study Intrathecal IgM Synthesis Is Associated with Spinal Cord Manifestation and Neuronal Injury in Early MS.
Ann Neurol. 2022; 91(6):814-820 Doi: 10.1002/ana.26348 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Paar, M; Seifried, K; Cvirn, G; Buchmann, A; Khalil, M; Oettl, K Redox State of Human Serum Albumin in Multiple Sclerosis: A Pilot Study.
Int J Mol Sci. 2022; 23(24): Doi: 10.3390/ijms232415806 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Pareto, D; Garcia-Vidal, A; Groppa, S; Gonzalez-Escamilla, G; Rocca, M; Filippi, M; Enzinger, C; Khalil, M; Llufriu, S; Tintoré, M; Sastre-Garriga, J; Rovira, À Prognosis of a second clinical event from baseline MRI in patients with a CIS: a multicenter study using a machine learning approach.
Neuroradiology. 2022; 64(7):1383-1390 Doi: 10.1007/s00234-021-02885-7
Web of Science PubMed FullText FullText_MUG

 

** Pirpamer, L; Kincses, B; Kincses, ZT; Kiss, C; Damulina, A; Khalil, M; Stollberger, R; Schmidt, R; Enzinger, C; Ropele, S Periventricular magnetisation transfer abnormalities in early multiple sclerosis.
Neuroimage Clin. 2022; 34: 103012 Doi: 10.1016/j.nicl.2022.103012 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Schoonheim, MM; Pinter, D; Prouskas, SE; Broeders, TA; Pirpamer, L; Khalil, M; Ropele, S; Uitdehaag, BM; Barkhof, F; Enzinger, C; Geurts, JJ Disability in multiple sclerosis is related to thalamic connectivity and cortical network atrophy.
Mult Scler. 2022; 28(1):61-70 Doi: 10.1177/13524585211008743
Web of Science PubMed FullText FullText_MUG

 

** Weiss, B; Pichler, A; Damulina, A; Buchmann, A; Hochmeister, S; Seifert-Held, T; Enzinger, C; Archelos, JJ; Khalil, M Evidence for an Intrathecal Immunoglobulin Synthesis by Kappa Free Light Chains in Neurological Patients with an Isolated Band in Isoelectric Focusing.
Biomedicines. 2022; 10(9): Doi: 10.3390/biomedicines10092202 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Woltsche, N; Valentin, K; Hoeflechner, L; Guttmann, A; Horwath-Winter, J; Schneider, MR; Ivastinovic, D; Lindner, M; Schmetterer, L; Singh, N; Riedl, R; Buchmann, A; Khalil, M; Lindner, E Neurofilament light chain: a new marker for neuronal decay in the anterior chamber fluid of patients with glaucoma.
Br J Ophthalmol. 2022; Doi: 10.1136/bjo-2021-320828
Web of Science PubMed FullText FullText_MUG

 

Abstract (Zeitschrift)

** Callegari, I; Oechtering, J; Kim, HI; Schneider, M; Holdermann, S; Kuhle, J; Khalil, M; Kapfhammer, J; Kappos, L; Junker, A; Sanderson, N; Derfuss, T Intrathecal IgM response in MS contains brain reactive antibodies
MULT SCLER J. 2022; 28(3_SUPPL):36-36.-38th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis; OCT 26-28, 2022; Amsterdam, NETHERLANDS. [Oral Communication]
Web of Science

 

** Demjaha, R; Hofer, E; Pirpamer, L; Buchmann, A; Pinter, D; Leppert, D; Benkert, P; Kuhle, J; Ropele, S; Schmidt, R; Cole, J; Enzinger, C; Khalil, M Serum neurofilament light levels in relation to the Brain-Age Paradigm in normal ageing
EUR J NEUROL. 2022; 29: 503-503. [Oral Communication]
Web of Science

 

** Demjaha, R; Hofer, E; Pirpamer, L; Buchmann, A; Pinter, D; Leppert, D; Benkert, P; Kuhle, J; Ropele, S; Schmidt, R; Cole, JH; Enzinger, C; Khalil, M Serum neurofilament light levels in relation to the Brain-Age Paradigm in normal ageing
MULT SCLER J. 2022; 28(3_SUPPL):588-589.-38th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis; OCT 26-28, 2022; Amsterdam, NETHERLANDS. [Oral Communication]
Web of Science

 

** Hanemann, CO; Abdelrahman, A; Adams, C; Sahm, F; Urbanic-Purkart, T; Khalil, M; Vergura, R; Morelli, C MIR-497 AND 219 IN BLOOD AID MENINGIOMA CLASSIFICATION MIR-497 AND 219 IN BLOOD AID MENINGIOMA CLASSIFICATION
NEURO-ONCOLOGY. 2022; 24: 17-17.-27th Annual Scientific Meeting and Education Day of the Society-for-Neuro-Oncology (SNO); NOV 16-20, 2022; Tampa, FL. [Oral Communication]
Web of Science

 

** Hechenberger, S; Helmlinger, B; Fruhwirth, V; Wurth, S; Damulina, A; Eppinger, S; Demjaha, R; Khalil, M; Enzinger, C; Pinter, D Evaluation of a Self-administered, IPad-based Processing Speed Test for People with Multiple Sclerosis
MULT SCLER J. 2022; 28(2_SUPPL): 12-13. [Poster]
Web of Science

 

** Hechenberger, S; Pirpamer, L; Fruhwirth, V; Berger, L; Helmlinger, B; Wurth, S; Damulina, A; Eppinger, S; Khalil, M; Enzinger, C; Penner, I; Pinter, D Structural Brain Changes Associated with Fatigue in People with Multiple Sclerosis
EUR J NEUROL. Proceedings of the 8th Congress of the EAN. 2022; 29: 222-222.-8th Congress of the European-Academy-of-Neurology (EAN); JUN 25-28, 2022; Vienna, AUSTRIA. [Poster]
Web of Science

 

** Hechenberger, S; Pirpamer, L; Helmlinger, B; Fruhwirth, V; Wurth, S; Damulina, A; Eppinger, S; Demjaha, R; Khalil, M; Enzinger, C; Penner, IK; Pinter, D Factors influencing fatigue in persons with multiple sclerosis: contribution of psychological and magnetic resonance imaging assessment
MULT SCLER J. 2022; 28(3_SUPPL): 436-437. [Poster]
Web of Science FullText

 

** Hegen, H; Arrambide, G; Berek, K; Gnanapavan, S; Kaplan, B; Khalil, M; Saadeh, R; Teunissen, C; Tumani, H; Villar, LM; Walde, J; Willrich, MAV; Zetterberg, H; Deisenhammer, F Cerebrospinal fluid kappa free light chains for the diagnosis of multiple sclerosis: a systematic review, meta-analysis and consensus statement
MULT SCLER J. 2022; 28(3_SUPPL):44-46.-38th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis; OCT 26-28, 2022; Amsterdam, NETHERLANDS. [Poster]
Web of Science

 

** Helmlinger, B; Hechenberger, S; Fruhwirth, V; Wurth, S; Damulina, A; Eppinger, S; Demjaha, R; Khalil, M; Enzinger, C; Pinter, D Self-efficacy influences depression and anxiety in a cross-sectional cohort of people with multiple sclerosis
MULT SCLER J. 2022; 28(3_SUPPL):907-907.-38th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis; OCT 26-28, 2022; Amsterdam, NETHERLANDS. [Poster]
Web of Science

 

** Khalil, M NfL use in clinical practice: normal reference values
MULT SCLER J. 2022; 28(3_SUPPL):121-122.-38th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis; OCT 26-28, 2022; Amsterdam, NETHERLANDS. [Oral Communication]
Web of Science

 

** Meier, S; Benkert, P; Maceski, A; Schaedelin, S; Garcia, LM; Cagol, A; Barakovic, M; Galbusera, R; Subramaniam, S; Achtnichts, L; Lalive, PH; Bridel, C; Muller, S; Pot, C; Salmen, A; Disanto, G; Zecca, C; Orleth, A; Khalil, M; Yaldizli, O; Oechtering, J; Battaglini, M; Kappos, L; Derfuss, T; Leppert, D; Gobbi, C; Granziera, C; Willemse, EAJ; Kuhle, J Serum glial fibrillary acidic protein compared with neurofilament light chain as biomarker for multiple sclerosis disease progression
MULT SCLER J. 2022; 28(3_SUPPL):122-123.-38th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis; OCT 26-28, 2022; Amsterdam, NETHERLANDS. [Oral Communication]
Web of Science

 

** Ruggieri, S; Prosperini, L; Al-Araji, S; Annovazzi, P; Bisecco, A; Ciccarelli, O; De Stefano, N; Filippi, M; Fleischer, V; Evangelou, N; Enzinger, C; Gallo, A; Garjani, A; Groppa, S; Haggiag, S; Khalil, M; Lucchini, M; Mirabella, M; Montalban, X; Pozzilli, C; Preziosa, P; Rio, J; Rocca, MA; Rovira, A; Stromillo, ML; Zaffaroni, M; Tortorella, C; Gasperini, C Assessing treatment response to oral drugs for multiple sclerosis in real world setting: a MAGNIMS study
MULT SCLER J. 2022; 28(3_SUPPL):657-659.-38th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis; OCT 26-28, 2022; Amsterdam, NETHERLANDS. [Poster]
Web of Science

 

** Weiss, B; Pichler, A; Damulina, A; Seifert-Held, T; Enzinger, C; Archelos-Garcia, J; Khalil, M Cerebrospinal fluid kappa free light chains in patients with an isolated band in isoelectric focusing
EUR J NEUROL. 2022; 29: 301-301. [Poster]
Web of Science

 

2021

Originalarbeit (Zeitschrift)

** Delaby, C; Teunissen, CE; Blennow, K; Alcolea, D; Arisi, I; Amar, EB; Beaume, A; Bedel, A; Bellomo, G; Bigot-Corbel, E; Bjerke, M; Blanc-Quintin, MC; Boada, M; Bousiges, O; Chapman, MD; DeMarco, ML; D'Onofrio, M; Dumurgier, J; Dufour-Rainfray, D; Engelborghs, S; Esselmann, H; Fogli, A; Gabelle, A; Galloni, E; Gondolf, C; Grandhomme, F; Grau-Rivera, O; Hart, M; Ikeuchi, T; Jeromin, A; Kasuga, K; Keshavan, A; Khalil, M; Körtvelyessy, P; Kulczynska-Przybik, A; Laplanche, JL; Lewczuk, P; Li, QX; Lleó, A; Malaplate, C; Marquié, M; Masters, CL; Mroczko, B; Nogueira, L; Orellana, A; Otto, M; Oudart, JB; Paquet, C; Paoletti, FP; Parnetti, L; Perret-Liaudet, A; Peoc'h, K; Poesen, K; Puig-Pijoan, A; Quadrio, I; Quillard-Muraine, M; Rucheton, B; Schraen, S; Schott, JM; Shaw, LM; Suárez-Calvet, M; Tsolaki, M; Tumani, H; Udeh-Momoh, CT; Vaudran, L; Verbeek, MM; Verde, F; Vermunt, L; Vogelgsang, J; Wiltfang, J; Zetterberg, H; Lehmann, S Clinical reporting following the quantification of cerebrospinal fluid biomarkers in Alzheimer's disease: An international overview.
Alzheimers Dement. 2021; Doi: 10.1002/alz.12545 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Fissolo, N; Matute-Blanch, C; Osman, M; Costa, C; Pinteac, R; Miró, B; Sanchez, A; Brito, V; Dujmovic, I; Voortman, M; Khalil, M; Borràs, E; Sabidó, E; Issazadeh-Navikas, S; Montalban, X; Comabella Lopez, M CSF SERPINA3 Levels Are Elevated in Patients With Progressive MS.
Neurol Neuroimmunol Neuroinflamm. 2021; 8(2): Doi: 10.1212/NXI.0000000000000941 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Koini, M; Pirpamer, L; Hofer, E; Buchmann, A; Pinter, D; Ropele, S; Enzinger, C; Benkert, P; Leppert, D; Kuhle, J; Schmidt, R; Khalil, M Factors influencing serum neurofilament light chain levels in normal aging.
Aging (Albany NY). 2021; 13(24):25729-25738 Doi: 10.18632/aging.203790 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Moser, T; Seiberl, M; Feige, J; Bieler, L; Radlberger, RF; O'Sullivan, C; Pilz, G; Harrer, A; Schwenker, K; Haschke-Becher, E; Machegger, L; Grimm, J; Redlberger-Fritz, M; Buchmann, A; Khalil, M; Kvas, E; Trinka, E; Wipfler, P Tetravalent Influenza Vaccine Is Not Associated With Neuroaxonal Damage in Multiple Sclerosis Patients.
Front Immunol. 2021; 12: 718895 Doi: 10.3389/fimmu.2021.718895 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Pinter, D; Khalil, M; Pirpamer, L; Damulina, A; Pichler, A; Fruhwirth, V; Ropele, S; Schmidt, R; Fuchs, S; Enzinger, C Long-term course and morphological MRI correlates of cognitive function in multiple sclerosis.
Mult Scler. 2021; 27(6):954-963 Doi: 10.1177/1352458520941474
Web of Science PubMed FullText FullText_MUG

 

** Pinter, D; Kober, SE; Fruhwirth, V; Berger, L; Damulina, A; Khalil, M; Neuper, C; Wood, G; Enzinger, C MRI correlates of cognitive improvement after home-based EEG neurofeedback training in patients with multiple sclerosis: a pilot study.
J Neurol. 2021; 268(10):3808-3816 Doi: 10.1007/s00415-021-10530-9 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Sareban, M; Berger, MM; Pinter, D; Buchmann, A; Macholz, F; Schmidt, P; Schiefer, L; Schimke, M; Niebauer, J; Steinacker, JM; Treff, G; Khalil, M Serum neurofilament level increases after ascent to 4559 m but is not related to acute mountain sickness.
Eur J Neurol. 2021; 28(3):1004-1008 Doi: 10.1111/ene.14606 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Schulz, E; Hodl, I; Forstner, P; Hatzl, S; Sareban, N; Moritz, M; Fessler, J; Dreo, B; Uhl, B; Url, C; Grisold, AJ; Khalil, M; Kleinhappl, B; Enzinger, C; Stradner, MH; Greinix, HT; Schlenke, P; Steinmetz, I CD19+IgD+CD27- Naïve B Cells as Predictors of Humoral Response to COVID 19 mRNA Vaccination in Immunocompromised Patients.
Front Immunol. 2021; 12:803742 Doi: 10.3389/fimmu.2021.803742 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Voortman, MM; Damulina, A; Pirpamer, L; Pinter, D; Pichler, A; Enzinger, C; Ropele, S; Bachmaier, G; Archelos, JJ; Marsche, G; Khalil, M Decreased Cerebrospinal Fluid Antioxidative Capacity Is Related to Disease Severity and Progression in Early Multiple Sclerosis.
Biomolecules. 2021; 11(9): Doi: 10.3390/biom11091264 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Abstract (Zeitschrift)

** Buchmann, A; Pirpamer, L; Pinter, D; Voortman, M; Helmlinger, B; Pichler, A; Bachmaier, G; Ropele, S; Enzinger, C; Khalil, M Serum Neurofilament Light Levels Correlate with Reduced Gray Matter Volume in Advanced Multiple Sclerosis
NEUROLOGY. 2021; 96(15): [Poster]
Web of Science FullText

 

** Filippi, M; Preziosa, P; Meani, A; Rovira, A; Mesaros, S; Ciccarelli, O; Battisti, JLF; Enzinger, C; Barkhof, F; Gasperini, C; Fainardi, E; Brownlee, W; Drulovic, J; Montalban, X; Cramer, SP; Khalil, M; Hagens, M; Ruggieri, S; Dalla Costa, G; Martinelli, V; Miszkiel, K; Tintore, M; Comi, G; Dekker, I; Uitdehaag, B; Ivanovic, J; Amato, MP; Rocca, MA Comparison of the 2017 and 2010 Revisions of the McDonald Criteria in Patients with CIS Suggestive of MS: A Multicentre MAGNIMS Study
NEUROLOGY. Supplement. 2021; 96(15): [Poster]
Web of Science

 

** Filippi, M; Preziosa, P; Meani, A; Rovira, A; Mesaros, S; Ciccarelli, O; Frederiksen, J; Enzinger, C; Barkhof, F; Gasperini, C; Fainardi, E; Brownlee, W; Drulovic, J; Montalban, X; Khalil, M; Hagens, M; Ruggieri, S; Dalla Costa, G; Tintore, M; Comi, G; Dekker, I; Uitdehaag, B; Ivanovic, J; Amato, M; Rocca, M Comparison of the 2017 and 2010 revisions of the McDonald criteria CIS patients: a multicentre MAGNIMS study
EUR J NEUROL. 2021; 28: 203-203.-EAN Virtual 2021; [Oral Communication]
Web of Science

 

** Hechenberger, S; Pirpamer, L; Fruhwirth, V; Berger, L; Helmlinger, B; Wurth, S; Damulina, A; Khalil, M; Enzinger, C; Penner, IK; Pinter, D Morphological correlates of fatigue in patients with multiple sclerosis
MULT SCLER J. 2021; 27(2_SUPPL): 257-258. [Poster]
Web of Science

 

** Helmlinger, B; Pinter, D; Gassner, B; Khalil, M; Heschl, B; Damulina, A; Pichler, A; Enzinger, C The timed 25-foot walk usefully complements the EDSS score in multiple sclerosis
MULT SCLER J. 2021; 27(2_SUPPL):266-266.-37th Congress of ECTRIMS; OCT 13-15; Basel, SWITZERLAND. [Poster]
Web of Science

 

** Koini, M; Pirpamer, L; Hofer, E; Buchmann, A; Pinter, D; Ropele, S; Enzinger, C; Benkert, P; Leppert, D; Kuhle, J; Schmidt, R; Khalil, M Factors influencing serum neurofilament light chain levels in normal ageing
MULT SCLER J. 2021; 27(2_SUPPL):504-504.-ECTRIMS; OCT 13-15, 2021; virtuell. [Poster]
Web of Science

 

** Lazzarotto, A; Hamzaoui, M; Tonietto, M; Ricigliano, VAG; Boffa, G; Khalil, M; Pirpamer, L; Ropele, S; Enzinger, C; Battaglini, M; Stromillo, ML; De Stefano, N; Rocca, MA; Gallo, P; Gasperini, C; Stankoff, B; Bodini, B Cortical remyelination predicts cortical atrophy and clinical progression in early multiple sclerosis
MULT SCLER J. 2021; 27(2_SUPPL):116-117.-ECTRIMS; Vienna, Austria. [Oral Communication]
Web of Science

 

** Pirpamer, L; Hofer, E; Buchmann, A; Pinter, D; Ropele, S; Enzinger, C; Benkert, P; Leppert, D; Kuhle, J; Schmidt, R; Khalil, M; Koini, M Factors influencing serum neurofilament light chain levels in normal ageing
EUR J NEUROL. 2021; 28: 256-256.-EAN Virtual; [Oral Communication]
Web of Science

 

2020

Originalarbeit (Zeitschrift)

** Bsteh, G; Berek, K; Hegen, H; Teuchner, B; Buchmann, A; Voortman, MM; Auer, M; Wurth, S; Zinganell, A; Di, Pauli, F; Deisenhammer, F; Khalil, M; Berger, T Serum neurofilament levels correlate with retinal nerve fiber layer thinning in multiple sclerosis.
Mult Scler. 2020; 26(13):1682-1690 Doi: 10.1177/1352458519882279
Web of Science PubMed FullText FullText_MUG

 

** Hässler, S; Bachelet, D; Duhaze, J; Szely, N; Gleizes, A; Hacein-Bey Abina, S; Aktas, O; Auer, M; Avouac, J; Birchler, M; Bouhnik, Y; Brocq, O; Buck-Martin, D; Cadiot, G; Carbonnel, F; Chowers, Y; Comabella, M; Derfuss, T; De Vries, N; Donnellan, N; Doukani, A; Guger, M; Hartung, HP; Kubala Havrdova, E; Hemmer, B; Huizinga, T; Ingenhoven, K; Hyldgaard-Jensen, PE; Jury, EC; Khalil, M; Kieseier, B; Laurén, A; Lindberg, R; Loercher, A; Maggi, E; Manson, J; Mauri, C; Mohand Oumoussa, B; Montalban, X; Nachury, M; Nytrova, P; Richez, C; Ryner, M; Sellebjerg, F; Sievers, C; Sikkema, D; Soubrier, M; Tourdot, S; Trang, C; Vultaggio, A; Warnke, C; Spindeldreher, S; Dönnes, P; Hickling, TP; Hincelin Mery, A; Allez, M; Deisenhammer, F; Fogdell-Hahn, A; Mariette, X; Pallardy, M; Broët, P; ABIRISK consortium Clinicogenomic factors of biotherapy immunogenicity in autoimmune disease: A prospective multicohort study of the ABIRISK consortium.
PLoS Med. 2020; 17(10): e1003348-e1003348. Doi: 10.1371/journal.pmed.1003348 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Khalil, M; Pirpamer, L; Hofer, E; Voortman, MM; Barro, C; Leppert, D; Benkert, P; Ropele, S; Enzinger, C; Fazekas, F; Schmidt, R; Kuhle, J Serum neurofilament light levels in normal aging and their association with morphologic brain changes.
Nat Commun. 2020; 11(1):812-812 Doi: 10.1038/s41467-020-14612-6 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Leurs, CE; Twaalfhoven, H; Lissenberg-Witte, BI; van, Pesch, V; Dujmovic, I; Drulovic, J; Castellazzi, M; Bellini, T; Pugliatti, M; Kuhle, J; Villar, LM; Alvarez-Cermeño, JC; Alvarez-Lafuente, R; Hegen, H; Deisenhammer, F; Walchhofer, LM; Thouvenot, E; Comabella, M; Montalban, X; Vécsei, L; Rajda, C; Galimberti, D; Scarpini, E; Altintas, A; Rejdak, K; Frederiksen, JL; Pihl-Jensen, G; Jensen, P; Khalil, M; Voortman, MM; Fazekas, F; Saiz, A; La, Puma, D; Vercammen, M; Vanopdenbosch, L; Uitdehaag, B; Killestein, J; Bridel, C; Teunissen, C Kappa free light chains is a valid tool in the diagnostics of MS: A large multicenter study.
Mult Scler. 2020; 26(8):912-923 Doi: 10.1177/1352458519845844 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Abstract (Zeitschrift)

** Buchmann, A; Pirpamer, L; Pinter, D; Voortman, M; Helmlinger, B; Pichler, A; Bachmaier, G; Ropele, S; Enzinger, C; Khalil, M Serum neurofilament light levels correlate with reduced grey matter volume in advanced multiple sclerosis.
MULT SCLER J. 2020; 26(3_SUPPL):192-193.-8th Joint ACTRIMS-ECTRIMS Meeting (MSVirtual); SEP 11-13, 2020; ELECTR NETWORK. [Onlinepräsentation]
Web of Science

 

** Colonna, I; Buchmann, A; Damulina, A; Pinter, D; Helmlinger, B; Pirpamer, L; Soellradl, M; Tinauer, C; Ropele, S; Enzinger, C; Schmidt, R; Khalil, M Comparison of deep grey matter iron deposition assessed by 3t mri r2(star) relaxometry in multiple sclerosis, alzheimer´s disease and in normal controls.
MULT SCLER J. 2020; 26(3_SUPPL):659-659.-8th Joint ACTRIMS-ECTRIMS Meeting (MSVirtual); SEP 11-13, 2020; ELECTR NETWORK. [Onlinepräsentation]
Web of Science

 

** Hechenberger, S; Pinter, D; Helmlinger, B; Pichler, A; Khalil, M; Enzinger, C Processing speed improves prediction of physical impairment in patients with multiple sclerosis.
MULT SCLER J. 2020; 26(3_SUPPL):509-510.-8th Joint ACTRIMS-ECTRIMS Meeting (MSVirtual); SEP 11-13, 2020; ELECTR NETWORK. [Poster]
Web of Science

 

** Helmlinger, B; Pinter, D; Ropele, S; Pirpamer, L; Khalil, M; Enzinger, C Multimodal mri of the brain to improve prediction of disease progression in multiple sclerosis.
MULT SCLER J. 2020; 26(3_SUPPL):409-409.-8th Joint ACTRIMS-ECTRIMS Meeting (MSVirtual); SEP 11-13, 2020; ELECTR NETWORK. [Onlinepräsentation]
Web of Science

 

** Pinter, D; Fruhwirth, V; Kober, S; Khalil, M; Neuper, C; Wood, G; Enzinger, C MRI correlates of cognitive improvement after home-based EEG neurofeedback training in MS: a pilot study.
MULT SCLER J. 2020; 26(3_SUPPL):32-32.-8th Joint ACTRIMS-ECTRIMS Meeting (MSVirtual); SEP 11-13, 2020; ELECTR NETWORK. [Oral Communication]
Web of Science

 

Abstract (Konferenzband)

** Buchmann, A; Pirpamer, L; Voortman, M; Pinter, D; Pichler, A; Bachmaier, G; Ropele, S; Enzinger, C; Fazekas, F; Khalil, M #2630 Serum Neurofilament Light Correlates with Reduced Grey Matter Volume in Advanced Multiple Sclerosis.
European Journal of Neurology, May 2020. 2020; 27(Suppl1):45-45.-6th EAN Congress; MAY 23-25, 2020 ; Paris, FRANCE. [Oral Communication]
Web of Science FullText

 

Guideline/Konsensuspapier

** Tumani, H; Petereit, HF; Gerritzen, A; Gross, CC; Huss, A; Isenmann, S; Jesse, S; Khalil, M; Lewczuk, P; Lewerenz, J; Leypoldt, F; Melzer, N; Meuth, SG; Otto, M; Ruprecht, K; Sindern, E; Spreer, A; Stangel, M; Strik, H; Uhr, M; Vogelgsang, J; Wandinger, KP; Weber, T; Wick, M; Wildemann, B; Wiltfang, J; Woitalla, D; Zerr, I; Zimmermann, T S1 guidelines "lumbar puncture and cerebrospinal fluid analysis" (abridged and translated version).
Neurological Research and Practice. 2020; 2(8): Doi: 10.1186/s42466-020-0051-z [OPEN ACCESS]
PubMed FullText FullText_MUG

 

2019

Originalarbeit (Zeitschrift)

** Bridel, C; van, Wieringen, WN; Zetterberg, H; Tijms, BM; Teunissen, CE; Alvarez-Cermeño, JC; Andreasson, U; Axelsson, M; Bäckström, DC; Bartos, A; Bjerke, M; Blennow, K; Boxer, A; Brundin, L; Burman, J; Christensen, T; Fialová, L; Forsgren, L; Frederiksen, JL; Gisslén, M; Gray, E; Gunnarsson, M; Hall, S; Hansson, O; Herbert, MK; Jakobsson, J; Jessen-Krut, J; Janelidze, S; Johannsson, G; Jonsson, M; Kappos, L; Khademi, M; Khalil, M; Kuhle, J; Landén, M; Leinonen, V; Logroscino, G; Lu, CH; Lycke, J; Magdalinou, NK; Malaspina, A; Mattsson, N; Meeter, LH; Mehta, SR; Modvig, S; Olsson, T; Paterson, RW; Pérez-Santiago, J; Piehl, F; Pijnenburg, YAL; Pyykkö, OT; Ragnarsson, O; Rojas, JC; Romme, Christensen, J; Sandberg, L; Scherling, CS; Schott, JM; Sellebjerg, FT; Simone, IL; Skillbäck, T; Stilund, M; Sundström, P; Svenningsson, A; Tortelli, R; Tortorella, C; Trentini, A; Troiano, M; Turner, MR; van, Swieten, JC; Vågberg, M; Verbeek, MM; Villar, LM; Visser, PJ; Wallin, A; Weiss, A; Wikkelsø, C; Wild, EJ, , and, the, NFL, Group Diagnostic Value of Cerebrospinal Fluid Neurofilament Light Protein in Neurology: A Systematic Review and Meta-analysis.
JAMA Neurol. 2019; 76(9):1035-1048 Doi: 10.1001/jamaneurol.2019.1534 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Bsteh, G; Berek, K; Hegen, H; Buchmann, A; Voortman, MM; Auer, M; Wurth, S; Zinganell, A; Di Pauli, F; Deisenhammer, F; Khalil, M; Berger, T Serum neurofilament light levels correlate with change of olfactory function in multiple sclerosis.
Mult Scler J Exp Transl Clin. 2019; 5(4): 2055217319885987-2055217319885987. Doi: 10.1177/2055217319885987 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Chatterjee, M; Koel-Simmelink, MJ; Verberk, IM; Killestein, J; Vrenken, H; Enzinger, C; Ropele, S; Fazekas, F; Khalil, M; Teunissen, CE Contactin-1 and contactin-2 in cerebrospinal fluid as potential biomarkers for axonal domain dysfunction in multiple sclerosis.
Mult Scler J Exp Transl Clin. 2019; 4(4):2055217318819535-2055217318819535 Doi: 10.1177/2055217318819535 [OPEN ACCESS]
PubMed FullText FullText_MUG

 

** Fissolo, N; Cervera-Carles, L; Villar Guimerans, LM; Lleó, A; Clarimón, J; Drulovic, J; Dujmovic, I; Voortman, M; Khalil, M; Gil, E; Navarro, L; Álvarez-Cermeño, JC; Montalban, X; Comabella, M Cerebrospinal fluid mitochondrial DNA levels in patients with multiple sclerosis.
Mult Scler. 2019; 25(11):1535-1538 Doi: 10.1177/1352458518786055
Web of Science PubMed FullText FullText_MUG

 

** International Multiple Sclerosis Genetics Consortium A systems biology approach uncovers cell-specific gene regulatory effects of genetic associations in multiple sclerosis.
Nat Commun. 2019; 10(1): 2236-2236. Doi: 10.1038/s41467-019-09773-y [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Jensen, PEH; Warnke, C; Ingenhoven, K; Piccoli, L; Gasis, M; Hermanrud, C; Fernandez-Rodriguez, BM; Ryner, M; Kramer, D; Link, J; Ramanujam, R; Auer, M; Buck, D; Grummel, V; Bertotti, E; Fissolo, N; Oliver-Martos, B; Nytrova, P; Khalil, M; Guger, M; Rathmaier, S; Sievers-Stober, C; Lindberg, RLP; Hässler, S; Bachelet, D; Aktas, O; Donnellan, N; Lawton, A; Hemmer, B; Havrdova, EK; Kieseier, B; Hartung, HP; Comabella, M; Montalban, X; Derfuss, T; Sellebjerg, F; Dönnes, P; Pallardy, M; Spindeldreher, S; Broët, P; Deisenhammer, F; Fogdell-Hahn, A; Sorensen, PS; ABIRISK Consortium Detection and kinetics of persistent neutralizing anti-interferon-beta antibodies in patients with multiple sclerosis. Results from the ABIRISK prospective cohort study.
J Neuroimmunol. 2019; 326:19-27 Doi: 10.1016/j.jneuroim.2018.11.002
Web of Science PubMed FullText FullText_MUG

 

** Pichler, A; Khalil, M; Langkammer, C; Pinter, D; Ropele, S; Fuchs, S; Bachmaier, G; Enzinger, C; Fazekas, F The impact of vascular risk factors on brain volume and lesion load in patients with early multiple sclerosis.
Mult Scler. 2019; 25(1):48-54 Doi: 10.1177/1352458517736149
Web of Science PubMed FullText FullText_MUG

 

** Pinter, D; Beckmann, CF; Fazekas, F; Khalil, M; Pichler, A; Gattringer, T; Ropele, S; Fuchs, S; Enzinger, C Morphological MRI phenotypes of multiple sclerosis differ in resting-state brain function.
Sci Rep. 2019; 9(1):16221-16221 Doi: 10.1038/s41598-019-52757-7 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Pinter, D; Gattringer, T; Enzinger, C; Seifert-Held, T; Kneihsl, M; Fandler, S; Pichler, A; Barro, C; Eppinger, S; Pirpamer, L; Bachmaier, G; Ropele, S; Wardlaw, JM; Kuhle, J; Khalil, M; Fazekas, F Longitudinal MRI dynamics of recent small subcortical infarcts and possible predictors.
J Cereb Blood Flow Metab. 2019; 39(9):1669-1677 Doi: 10.1177/0271678X18775215 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Walleczek, NK; Frommlet, F; Bsteh, G; Eggers, C; Rauschka, H; Koppi, S; Assar, H; Ehling, R; Birkl, C; Salhofer-Polanyi, S; Baumgartner, A; Blechinger, S; Buchinger, D; Sellner, J; Kraus, J; Moser, H; Mayr, M; Guger, M; Rathmaier, S; Raber, B; Liendl, H; Hiller, MS; Parigger, S; Morgenstern, G; Kempf, I; Spiss, HK; Meister, B; Heine, M; Cisar, A; Bachler, H; Khalil, M; Fuchs, S; Enzinger, C; Fazekas, F; Leutmezer, F; Berger, T; Kristoferitsch, W; Aboulenein-Djamshidian, F Month-of-birth-effect in multiple sclerosis in Austria.
Mult Scler. 2019; 25(14):1870-1877 Doi: 10.1177/1352458518810924
Web of Science PubMed FullText FullText_MUG

 

Korrektur

** International Multiple Sclerosis Genetics Consortium Author Correction: A systems biology approach uncovers cell-specific gene regulatory effects of genetic associations in multiple sclerosis.
Nat Commun. 2019; 10(1):2956-2956 Doi: 10.1038/s41467-019-10951-1 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Abstract (Zeitschrift)

** Bsteh, G; Berek, K; Hegen, H; Teuchner, B; Auer, M; Wurth, S; Zinganell, A; Di Pauli, F; Deisenhammer, F; Khalil, M; Berger, T Serum neurofilament light chain levels correlate with peripapillary retinal nerve fibre layerthinning as measured by optical coherence tomography in multiple sclerosis
MULT SCLER J. 2019; 25: 109-110.-35th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS) / 24th Annual Conference of Rehabilitation in MS; SEP 11-13, 2019; Stockholm, SWEDEN. [Oral Communication]
Web of Science

 

** Khalil, M; Pirpamer, L; Hofer, E; Voortman, M; Barro, C; Leppert, D; Benkert, P; Ropele, S; Enzinger, C; Fazekas, F; Schmidt, R; Kuhle, J Serum neurofilament light levels in normal aging: associations with morphologic brain changes
EUR J NEUROL. 2019; 26: 17-18. [Oral Communication]
Web of Science

 

** Pinter, D; Khalil, M; Pirpamer, L; Damulina, A; Fruhwirth, V; Pichler, A; Fuchs, S; Fazekas, F; Enzinger, C Diagnosis and monitoring of MS associated neurocognitive disorder: tests, assessment tools, computer interface etc
MULT SCLER J. 2019; 25(8):NP12-NP12.-Annual Meeting of the International-Multiple-Sclerosis-Cognition-Society (IMSCOGS); JUN 06-07, 2019; Amsterdam, NETHERLANDS. [Oral Communication]
Web of Science

 

** Pinter, D; Khalil, M; Pirpamer, L; Damulina, A; Fruhwirth, V; Pichler, A; Fuchs, S; Fazekas, F; Enzinger, C The evolution of cognitive function in MS over ten years and the association with MRI findings
MULT SCLER J. 2019; 25: 400-401.-35th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS) / 24th Annual Conference of Rehabilitation in MS; SEP 11-13, 2019; Stockholm, SWEDEN. [Oral Communication]
Web of Science

 

** Stryeck, S; Voortman, M; Enzinger, C; Fuchs, S; Deisenhammer, F; Hegen, H; Fazekas, F; Madl, T; Khalil, M Serum NMR spectroscopy metabolomic profiles indicate progressive multiple sclerosis
EUR J NEUROL. 2019; 26: 241-241. [Poster]
Web of Science

 

2018

Originalarbeit (Zeitschrift)

** Voortman, MM; Greiner, P; Moser, D; Stradner, MH; Graninger, W; Moser, A; Haditsch, B; Enzinger, C; Fuchs, S; Fazekas, F; Fessler, J; Khalil, M The effect of disease modifying therapies on CD62L expression in multiple sclerosis.
Mult Scler J Exp Transl Clin. 2018; 4(3):2055217318800810-2055217318800810 Doi: 10.1177/2055217318800810 [OPEN ACCESS]
PubMed FullText FullText_MUG

 

Übersichtsarbeit

** Khalil, M; Teunissen, CE; Otto, M; Piehl, F; Sormani, MP; Gattringer, T; Barro, C; Kappos, L; Comabella, M; Fazekas, F; Petzold, A; Blennow, K; Zetterberg, H; Kuhle, J Neurofilaments as biomarkers in neurological disorders.
Nat Rev Neurol. 2018; 14(10):577-589 Doi: 10.1038/s41582-018-0058-z
Web of Science PubMed FullText FullText_MUG

 

Editorial

** Khalil, M Are neurofilaments valuable biomarkers for long-term disease prognostication in MS?
Mult Scler. 2018; 24(10):1270-1271 Doi: 10.1177/1352458518791518 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Abstract (Zeitschrift)

** Hallwirth, F; Moser, D; Voortman, M; Greiner, P; Fuchs, S; Enzinger, C; Bachmaier, G; Gruber, HJ; Fazekas, F; Khalil, M Immunomodulatory therapy reduces elevated nitric oxide levels in multiple sclerosis patients
EUR J NEUROL. 2018; 25: 254-254.-4th Congress of the European Academy of Neurology (EAN); JUN 16-19, 2018; Lisbon, PORTUGAL. [Poster]
Web of Science

 

** Khalil, M; Pirpamer, L; Hofer, E; Voortman, MM; Hallwirth, F; Barro, C; Fazekas, F; Schmidt, R; Kuhle, J Normative values of serum neurofilament light levels
Multiple Sclerosis Journal, ECTRIMS 2018. 2018; 24(S2):657-658.-34th Congress of the European Committee for Treatment and Research of Multiple Sclerosis (ECTRIMS); OCT 10-12, 2018; Berlin, GERMANY. [Poster]
Web of Science FullText

 

** Kuhle, J; Barro, C; Hrusovsky, K; Chang, L; Jeromin, A; Bridel, C; Bar-Or, A; Bittner, S; Bruck, W; Bielekova, B; Chitnis, T; Comi, G; Comabella, M; Arrambide, G; Montalban, X; Datwani, A; Fluck, M; Fox, R; Freedman, M; Furlan, R; Gnanapavan, S; Giovannoni, G; Havari, E; Khalil, M; Leppert, D; Kropshofer, H; Valentin, MA; Oksenberg, J; Piehl, F; Plavina, T; Sormani, MP; Lehmann, S; Thouvenot, E; Ziemssen, T; Zipp, F; Gross, C; Wiendl, H; Kappos, L; Michalak, Z; Blennow, K; Zetterberg, H; Teunissen, C; Wilson, D International multi-site analytical validation of the Simoa NF-light assay in human serum samples from multiple sclerosis patients
MULT SCLER J. 2018; 24: 249-251.-34th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS); OCT 10-12, 2018; Berlin, GERMANY. [Poster]
Web of Science

 

** Pichler, A; Hochstrasser, D; Khalil, M; Langkammer, C; Pirpamer, L; Pinter, D; Ropele, S; Fuchs, S; Enzinger, C; Fazekas, F The effect of smoking on 'normal appearing white matter' and lesion load in periventricular regions of patients with multiple sclerosis
MULT SCLER J. 2018; 24: 582-582. [Poster]
Web of Science

 

** Schoonheim, MM; Pinter, D; Meijer, KA; Eijlers, AJC; Pirpamer, L; Khalil, M; Pichler, A; Fuchs, S; Fazekas, F; Uitdehaag, BMJ; Barkhof, F; Enzinger, C; Geurts, JJG Specific patterns of thalamic functional connectivity changes related to disability and cognitive impairment in multiple sclerosis
MULT SCLER J. 2018; 24: 613-614. [Poster]
Web of Science

 

** Voortman, MM; Greiner, P; Moser, D; Stradner, MH; Graninger, W; Moser, A; Haditsch, B; Enzinger, C; Fuchs, S; Fazekas, F; Fessler, J; Khalil, M The effect of disease modifying therapies on CD62L expression in multiple sclerosis.
Multiple Sclerosis Journal, ECTRIMS 2018. 2018; 24(S2):255-255.-34th Congress of the European Committee for Treatment and Research of Multiple Sclerosis (ECTRIMS); OCT 10-12, 2018; Berlin, GERMANY. [Poster]
Web of Science FullText

 

2017

Originalarbeit (Zeitschrift)

** Borsodi, F; Culea, V; Langkammer, C; Khalil, M; Pirpamer, L; Quasthoff, S; Enzinger, C; Schmidt, R; Fazekas, F; Ropele, S Multimodal assessment of white matter tracts in amyotrophic lateral sclerosis.
PLoS One. 2017; 12(6):e0178371-e0178371 Doi: 10.1371/journal.pone.0178371 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Engelborghs, S; Niemantsverdriet, E; Struyfs, H; Blennow, K; Brouns, R; Comabella, M; Dujmovic, I; van der Flier, W; Frölich, L; Galimberti, D; Gnanapavan, S; Hemmer, B; Hoff, E; Hort, J; Iacobaeus, E; Ingelsson, M; Jan de Jong, F; Jonsson, M; Khalil, M; Kuhle, J; Lleó, A; de Mendonça, A; Molinuevo, JL; Nagels, G; Paquet, C; Parnetti, L; Roks, G; Rosa-Neto, P; Scheltens, P; Skårsgard, C; Stomrud, E; Tumani, H; Visser, PJ; Wallin, A; Winblad, B; Zetterberg, H; Duits, F; Teunissen, CE Consensus guidelines for lumbar puncture in patients with neurological diseases.
Alzheimers Dement (Amst). 2017; 8(6):111-126 Doi: 10.1016/j.dadm.2017.04.007 [OPEN ACCESS]
PubMed FullText FullText_MUG

 

** Gattringer, T; Pinter, D; Enzinger, C; Seifert-Held, T; Kneihsl, M; Fandler, S; Pichler, A; Barro, C; Gröbke, S; Voortman, M; Pirpamer, L; Hofer, E; Ropele, S; Schmidt, R; Kuhle, J; Fazekas, F; Khalil, M Serum neurofilament light is sensitive to active cerebral small vessel disease.
Neurology. 2017; 89(20):2108-2114 Doi: 10.1212/WNL.0000000000004645 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Moser, AM; Spindelboeck, W; Strohmaier, H; Enzinger, C; Gattringer, T; Fuchs, S; Fazekas, F; Gorkiewicz, G; Wurm, P; Högenauer, C; Khalil, M Mucosal biopsy shows immunologic changes of the colon in patients with early MS.
Neurol Neuroimmunol Neuroinflamm. 2017; 4(4):e362-e362 Doi: 10.1212/NXI.0000000000000362 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Voortman, MM; Pekar, T; Bachmayer, D; Archelos, JJ; Stojakovic, T; Scharnagl, H; Ropele, S; Pichler, A; Enzinger, C; Fuchs, S; Fazekas, F; Seifert-Held, T; Khalil, M Serum netrin-1 in relation to gadolinium-enhanced magnetic resonance imaging in early multiple sclerosis.
Mult Scler J Exp Transl Clin. 2017; 3(3):2055217317727294-2055217317727294 Doi: 10.1177/2055217317727294 [OPEN ACCESS]
PubMed FullText FullText_MUG

 

** Voortman, MM; Stojakovic, T; Pirpamer, L; Jehna, M; Langkammer, C; Scharnagl, H; Reindl, M; Ropele, S; Seifert-Held, T; Archelos, JJ; Fuchs, S; Enzinger, C; Fazekas, F; Khalil, M Prognostic value of free light chains lambda and kappa in early multiple sclerosis.
Mult Scler. 2017; 23(11):1496-1505 Doi: 10.1177/1352458516681503 [Oral Communication]
Web of Science PubMed FullText FullText_MUG

 

Korrespondenz

** Gattringer, T; Khalil, M; Langkammer, C; Pinter, D; Ropele, S; Fazekas, F; Enzinger, C Comment on the letter to the editor entitled "Brain iron deposition in patients with white matter hyperintensities of presumed vascular origin" by D. Zhou.
Neurobiol Aging. 2017; 53(5): 198-198. Doi: 10.1016/j.neurobiolaging.2016.09.026
Web of Science PubMed FullText FullText_MUG

 

Abstract (Zeitschrift)

** Fissolo, N; Issazadeh-Navikas, S; Dujmovic, I; Voortman, MM; Khalil, M; Montalban, X; Comabella, M. Serpina3n: potential biomarker in patients with progressive multiple sclerosis.
Multiple Sclerosis Journal. 2017; 23(S3):219-219.-7th Joint ECTRIMS-ACTRIMS (European-Americas Committee for Treatment and Research of Multiple Sclerosis) Meeting ; OCT 25-28, 2017; Paris, FRANCE. [Poster]
Web of Science FullText

 

** Gattringer, T; Pinter, D; Enzinger, C; Kneihsl, M; Fandler, S; Pichler, A; Barro, C; Grobke, S; Voortman, M; Seifert-Held, T; Pirpamer, L; Hofer, E; Ropele, S; Schmidt, R; Kuhle, J; Fazekas, F; Khalil, M Serum neurofilament light chain protein: A promising biomarker for lacunar stroke and cerebral small vessel disease.
EUR J NEUROL. 2017; 24: 462-462.-3rd Congress of the European Academy of Neurology (EAN); JUN 24-27, 2017; Amsterdam, THE NETHERLANDS. [Oral Communication]
Web of Science

 

** Hallwirth, F; Moser, D; Voortman, MM; Greiner, P; Fuchs, S; Enzinger, C; Bachmaier, G; Gruber, H-J; Fazekas; Khalil, M Serum nitric oxide is increased in untreated multiple sclerosis patients.
Mult Scler J. 2017; 23(S3):586-587.-7th Joint ECTRIMS-ACTRIMS (European-Americas Committee for Treatment and Research of Multiple Sclerosis) Meeting ; OCT 25-28, 2017; Paris, FRANCE. [Poster]
Web of Science

 

** Leurs CE; Twaalfhoven, HAM; Witte, BI; Van Pesch, V; Dujmovic, I; Drulovic, J; Castellazzi, M; Bellini, T; Pugliatti, M; Kuhle, J; Villar, LM; Alvarez Cermeño, JC; Alvarez-Lafuente, R; Hegen, H; Deisenhammer, F; Thouvenot, E; Comabella, M; Montalban, X; Vécsei, L; Rajda, C; Galimberti, D; Altintas, A; Rejdak, K; Frederiksen, JL; Pihl-Jensen, G; Jensen, PE; Khalil, M; Voortman, MM; Fazekas, F; Saiz, A; La Puma, D; Vercammen, MJ; VanopdenBosch, L; Uitdehaag, BMJ; Killestein, J; Teunissen, C. Kappa free light chains: an automated alternative to oligoclonal bands for CIS and MS diagnosis?
Multiple Sclerosis Journal. 2017; 23(S3):591-592.-7th Joint ECTRIMS-ACTRIMS (European-Americas Committee for Treatment and Research of Multiple Sclerosis) Meeting ; OCT 25-28, 2017; Paris, FRANCE. [Poster]
Web of Science FullText

 

** Pinter, D; Beckmann, C; Fazekas, F; Khalil, M; Pichler, A; Ropele, S; Fuchs, S; Enzinger, C Morphologic MRI phenotyping of multiple sclerosis associates with altered brain function
MULT SCLER J. 2017; 23: 539-540. [Poster]
Web of Science

 

** Pinter, D; Fazekas, F; Damulina, A; Pirpamer, L; Pichler, A; Khalil, M; Ropele, S; Fuchs, S; Enzinger, C Evolution of cognitive function in MS and its relationship to physical disability and MRI metrics
MULT SCLER J. 2017; 23: 285-286. [Poster]
Web of Science

 

** Pinter, D; Pirpamer, L; Damulina, A; Fazekas, F; Pichler, A; Khalil, M; Fuchs, S; Enzinger, C Long-term course of cognitive function and disability in patients with MS
MULT SCLER J. 2017; 23(8): NP1-NP1. [Oral Communication]
Web of Science

 

** Voortman, M; Pekar, T; Bachmayer, D; Archelos-Garcia, JJ; Stojakovic, T; Scharnagl, H; Ropele, S; Pichler, A; Enzinger, C; Fuchs, S; Fazekas, F; Seifert-Held, T; Khalil, M The role of serum netrin-1 in early multiple sclerosis.
EUR J NEUROL. Eur J Neurol 2017; 24 (Suppl 1). 2017; 24: 313-313.-3rd Congress of the European Academy of Neurology (EAN); JUN 24-27, 2017; Amsterdam, THE NETHERLANDS. [Poster]
Web of Science FullText

 

Abstract (Konferenzband)

** Voortman, MM; Pichler, A; Enzinger, C; Fuchs, S; Bachmaier, G; Archelos, JJ; Fazekas, F; Marsche, G; Khalil, M Decreased cerebrospinal fluid antioxidative capacity is associated with disease severity and progression in early multiple sclerosis.
Multiple Sclerosis Journal. 2017; 23(S3):303-304.-7th Joint ECTRIMS-ACTRIMS (European-Americas Committee for Treatment and Research of Multiple Sclerosis) Meeting; OCT 25-28, 2017; Paris, FRANCE. [Poster]
Web of Science FullText

 

2016

Originalarbeit (Zeitschrift)

** Gattringer, T; Khalil, M; Langkammer, C; Jehna, M; Pichler, A; Pinter, D; Kneihsl, M; Petrovic, K; Ropele, S; Fazekas, F; Enzinger, C No evidence for increased brain iron deposition in patients with ischemic white matter disease.
Neurobiol Aging. 2016; 45(7):61-63 Doi: 10.1016/j.neurobiolaging.2016.05.008
Web of Science PubMed FullText FullText_MUG

 

** Hegen, H; Adrianto, I; Lessard, CJ; Millonig, A; Bertolotto, A; Comabella, M; Giovannoni, G; Guger, M; Hoelzl, M; Khalil, M; Fazekas, F; Killestein, J; Lindberg, RL; Malucchi, S; Mehling, M; Montalban, X; Rudzki, D; Schautzer, F; Sellebjerg, F; Sorensen, PS; Deisenhammer, F; Steinman, L; Axtell, RC Cytokine profiles show heterogeneity of interferon-β response in multiple sclerosis patients.
Neurol Neuroimmunol Neuroinflamm. 2016; 3(2):e202-e202 Doi: 10.1212/NXI.0000000000000202 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Khalil, M; Renner, A; Langkammer, C; Enzinger, C; Ropele, S; Stojakovic, T; Scharnagl, H; Bachmaier, G; Pichler, A; Archelos, JJ; Fuchs, S; Seifert-Held, T; Fazekas, F Cerebrospinal fluid lipocalin 2 in patients with clinically isolated syndromes and early multiple sclerosis.
Mult Scler. 2016; 22(12):1560-1568 Doi: 10.1177/1352458515624560
Web of Science PubMed FullText FullText_MUG

 

** Kneihsl, M; Enzinger, C; Wünsch, G; Khalil, M; Culea, V; Urbanic-Purkart, T; Payer, F; Niederkorn, K; Fazekas, F; Gattringer, T Poor short-term outcome in patients with ischaemic stroke and active cancer.
J Neurol. 2016; 263(1):150-156 Doi: 10.1007/s00415-015-7954-6 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Pichler, A; Khalil, M; Langkammer, C; Pinter, D; Bachmaier, G; Ropele, S; Fuchs, S; Enzinger, C; Fazekas, F Combined analysis of global and compartmental brain volume changes in early multiple sclerosis in clinical practice.
Mult Scler. 2016; 22(3):340-346 Doi: 10.1177/1352458515593405
Web of Science PubMed FullText FullText_MUG

 

** Tuller, F; Holzer, H; Schanda, K; Aboulenein-Djamshidian, F; Höftberger, R; Khalil, M; Seifert-Held, T; Leutmezer, F; Berger, T; Reindl, M Characterization of the binding pattern of human aquaporin-4 autoantibodies in patients with neuromyelitis optica spectrum disorders.
J Neuroinflammation. 2016; 13(1):176-176 Doi: 10.1186/s12974-016-0642-3 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Editorial

** Khalil, M; Salzer, J CSF neurofilament light: A universal risk biomarker in multiple sclerosis?
Neurology. 2016; 87(11):1068-1069 Doi: 10.1212/WNL.0000000000003107
Web of Science PubMed FullText FullText_MUG

 

Abstract (Zeitschrift)

** Pichler, A; Khalil, M; Langkammer, C; Pinter, D; Ropele, S; Fuchs, S; Enzinger, C; Fazekas, F The impact of cardiovascular comorbidities on the temporal evolution of brain volume and lesion load in early multiple sclerosis.
MULT SCLER J. 2016; 22: 70-70.-32nd Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS); SEP 14-17, 2016; London, ENGLAND. [Oral Communication]
Web of Science

 

** Pinter, D; Khalil, M; Greiner, P; Moser, D; Koini, M; Pirker, E; Pichler, A; Bachmaier, G; Ropele, S; Fuchs, S; Fazekas, F; Enzinger, C The relationship between resting-state connectivity alterations and the extent of focal white matter lesion changes in multiple sclerosis
MULT SCLER J. 2016; 22: 759-759.
Web of Science

 

** Pinter, D; Khalil, M; Greiner, P; Moser, D; Pirker, E; Pichler, A; Bachmaier, G; Ropele, S; Fuchs, S; Fazekas, F; Enzinger, C Lesion filling more strongly affects estimation of grey than white matter volumes in a large patient sample depending on hyperintense lesion load
MULT SCLER J. 2016; 22: 512-512.
Web of Science

 

** Spindelboeck, W; Moser, AM; Strohmaier, H; Enzinger, C; Gattringer, T; Fuchs, S; Fazekas, F; Gorkiewicz, G; Wurm, P; Hogenauer, C; Khalil, M Mucosal biopsy reveals immunologic changes of the colon in patients with early multiple sclerosis
MULT SCLER J. 2016; 22: 179-179.
Web of Science

 

** Voortman, M; Bachmayer, D; Seifert-Held, T; Archelos, JJ; Ropele, S; Pichler, A; Enzinger, C; Fuchs, S; Fazekas, F; Khalil, M No association of serum Netrin-1 with MRI based evidence of disease activity in early multiple sclerosis.
MULT SCLER J. 2016; 22: 274-274.-32nd Congress of the European Committee for Treatment and Research in Multiple-Sclerosis (ECTRIMS); SEP 14-17, 2016; London, UNITED KINGDOM. [Poster]
Web of Science

 

2015

Originalarbeit (Zeitschrift)

** Cantó, E; Tintoré, M; Villar, LM; Costa, C; Nurtdinov, R; Álvarez-Cermeño, JC; Arrambide, G; Reverter, F; Deisenhammer, F; Hegen, H; Khademi, M; Olsson, T; Tumani, H; Rodríguez-Martín, E; Piehl, F; Bartos, A; Zimova, D; Kotoucova, J; Kuhle, J; Kappos, L; García-Merino, JA; Sánchez, AJ; Saiz, A; Blanco, Y; Hintzen, R; Jafari, N; Brassat, D; Lauda, F; Roesler, R; Rejdak, K; Papuc, E; de Andrés, C; Rauch, S; Khalil, M; Enzinger, C; Galimberti, D; Scarpini, E; Teunissen, C; Sánchez, A; Rovira, A; Montalban, X; Comabella, M Chitinase 3-like 1: prognostic biomarker in clinically isolated syndromes.
Brain. 2015; 138(Pt 4):918-931 Doi: 10.1093/brain/awv017 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Gattringer, T; Enzinger, C; Fischer, R; Seyfang, L; Niederkorn, K; Khalil, M; Ferrari, J; Lang, W; Brainin, M; Willeit, J; Fazekas, F IV thrombolysis in patients with ischemic stroke and alcohol abuse.
Neurology. 2015; 85(18):1592-1597 Doi: 10.1212/WNL.0000000000002078
Web of Science PubMed FullText FullText_MUG

 

** Jehna, M; Pirpamer, L; Khalil, M; Fuchs, S; Ropele, S; Langkammer, C; Pichler, A; Stulnig, F; Deutschmann, H; Fazekas, F; Enzinger, C Periventricular lesions correlate with cortical thinning in multiple sclerosis.
Ann Neurol. 2015; 78(4): 530-539. Doi: 10.1002/ana.24461
Web of Science PubMed FullText FullText_MUG

 

** Khalil, M; Langkammer, C; Pichler, A; Pinter, D; Gattringer, T; Bachmaier, G; Ropele, S; Fuchs, S; Enzinger, C; Fazekas, F Dynamics of brain iron levels in multiple sclerosis: A longitudinal 3T MRI study.
Neurology. 2015; 84(24): 2396-2402. Doi: 10.1212/WNL.0000000000001679
Web of Science PubMed FullText FullText_MUG

 

** Kuhle, J; Disanto, G; Dobson, R; Adiutori, R; Bianchi, L; Topping, J; Bestwick, JP; Meier, UC; Marta, M; Dalla Costa, G; Runia, T; Evdoshenko, E; Lazareva, N; Thouvenot, E; Iaffaldano, P; Direnzo, V; Khademi, M; Piehl, F; Comabella, M; Sombekke, M; Killestein, J; Hegen, H; Rauch, S; D'Alfonso, S; Alvarez-Cermeño, JC; Kleinová, P; Horáková, D; Roesler, R; Lauda, F; Llufriu, S; Avsar, T; Uygunoglu, U; Altintas, A; Saip, S; Menge, T; Rajda, C; Bergamaschi, R; Moll, N; Khalil, M; Marignier, R; Dujmovic, I; Larsson, H; Malmestrom, C; Scarpini, E; Fenoglio, C; Wergeland, S; Laroni, A; Annibali, V; Romano, S; Martínez, AD; Carra, A; Salvetti, M; Uccelli, A; Torkildsen, Ø; Myhr, KM; Galimberti, D; Rejdak, K; Lycke, J; Frederiksen, JL; Drulovic, J; Confavreux, C; Brassat, D; Enzinger, C; Fuchs, S; Bosca, I; Pelletier, J; Picard, C; Colombo, E; Franciotta, D; Derfuss, T; Lindberg, R; Yaldizli, Ö; Vécsei, L; Kieseier, BC; Hartung, HP; Villoslada, P; Siva, A; Saiz, A; Tumani, H; Havrdová, E; Villar, LM; Leone, M; Barizzone, N; Deisenhammer, F; Teunissen, C; Montalban, X; Tintoré, M; Olsson, T; Trojano, M; Lehmann, S; Castelnovo, G; Lapin, S; Hintzen, R; Kappos, L; Furlan, R; Martinelli, V; Comi, G; Ramagopalan, SV; Giovannoni, G Conversion from clinically isolated syndrome to multiple sclerosis: A large multicentre study.
Mult Scler. 2015; 21(8):1013-1024 Doi: 10.1177/1352458514568827
Web of Science PubMed FullText FullText_MUG

 

** Pinter, D; Khalil, M; Pichler, A; Langkammer, C; Ropele, S; Marschik, PB; Fuchs, S; Fazekas, F; Enzinger, C Predictive value of different conventional and non-conventional MRI-parameters for specific domains of cognitive function in multiple sclerosis.
Neuroimage Clin. 2015; 7(4):715-720 Doi: 10.1016/j.nicl.2015.02.023 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Abstract (Zeitschrift)

** Gattringer, T; Kneihsl, M; Enzinger, C; Wunsch, G; Khalil, M; Urbanic-Purkart, T; Payer, F; Niederkorn, K; Fazekas, F Poor short-term outcome in patients with ischemic stroke and active cancer
EUR J NEUROL. 2015; 22: 228-228.-1st Congress of the European-Academy-of-Neurology; JUN, 2015; Berlin, GERMANY. [Poster]
Web of Science

 

** Jehna, M; Pirpamer, L; Khalil, M; Fuchs, S; Ropele, S; Langkammer, C; Pichler, A; Stulnig, F; Deutschmann, H; Fazekas, F; Enzinger, C Periventricular lesion burden in multiple sclerosis correlates with cortical thinning
MULT SCLER J. 2015; 21: 180-181.-31st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS); OCT 07-10, 2015; Barcelona, SPAIN. Doi: 10.1177/135245851560 [Poster]
Web of Science FullText FullText_MUG

 

** Jehna, M; Pirpamer, L; Khalil, M; Stulnig, F; Fuchs, S; Ropele, S; Langkammer, C; Pichler, A; Deutschmann, H; Fazekas, F; Enzinger, C Periventricular lesion burden in multiple sclerosis correlates with cortical thinning
EUR J NEUROL. 2015; 22: 155-155.-1st Congress of the European-Academy-of-Neurology; JUN, 2015; Berlin, GERMANY. [Poster]
Web of Science FullText

 

** Khalil, M; Renner, A; Langkammer, C; Enzinger, C; Ropele, S; Stojakovic, T; Scharnagl, H; Archelos-Garcia, JJ; Fuchs, S; Seifert-Held, T; Fazekas, F Cerebrospinal fluid lipocalin-2 levels are reduced in multiple sclerosis and correlate with putaminal iron accumulation
EUR J NEUROL. 2015; 22: 87-87.-1st Congress of the European-Academy-of-Neurology; JUN, 2015; Berlin, GERMANY. [Poster]
Web of Science

 

** Khalil, M; Renner, A; Langkammer, C; Enzinger, C; Ropele, S; Stojakovic, T; Scharnagl, H; Bachmaier, G; Archelos, JJ; Fuchs, S; Seifert-Held, T; Fazekas, F Impact of cerebrospinal fluid lipocalin-2 on brain iron accumulation and clinical progression in multiple sclerosis
MULT SCLER J. 2015; 21: 632-632.-31st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS); OCT 07-10, 2015; Barcelona, SPAIN. [Poster]
Web of Science

 

** Voortman, M; Stojakovic, T; Jehna, M; Scharnagl, H; Ropele, S; Seifert-Held, T; Archelos-Garcia, JJ; Fuchs, S; Enzinger, C; Fazekas, F; Khalil, M Cerebrospinal fluid free light chains are elevated in clinically isolated syndrome and multiple sclerosis and correlate with lesion load and cortical thinning.
EUR J NEUROL. 2015; 22: 398-398.-1st Congress of the European Academy of Neurology (EAN); JUN, 2015; Berlin, GERMANY. [Poster]
Web of Science

 

** Voortman, MM; Stojakovic, T; Jehna, M; Scharnagl, H; Ropele, S; Seifert-Held, T; Archelos, JJ; Fuchs, S; Enzinger, C; Fazekas, F; Khalil, M Increased cerebrospinal fluid immunoglobulin free light chain levels in relation to lesion load and cortical thinning of multiple sclerosis patients
MULT SCLER J. 2015; 21: 630-630.-31st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS); OCT 07-10, 2015; Barcelona, SPAIN. [Poster]
Web of Science

 

** Walleczek, NK; Rauschka, H; Bsteh, G; Birkl, CB; Khalil, M; Fuchs, S; Enzinger, C; Fazekas, F; Eggers, C; Leutmezer, F; Salhofer-Polanyi, S; Baumgartner, A; Blechinger, S; Koppi, S; Sellner, J; Kraus, J; Assar, H; Gugger, M; Ehling, R; Moser, H; Raber, B; Liendl, H; Parigger, S; Mayr, M; Hiller, MS; Meister, B; Morgenstern, G; Spiess, HK; Kempf, I; Cisar, A; Bachler, H; Lehninger, R; Berger, T; Kristoferitsch, W; Aboulenein-Djamshidian, F Month-of-birth-effect in multiple sclerosis in Austria
MULT SCLER J. 2015; 21: 102-103.-31st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS); OCT 07-10, 2015; Barcelona, SPAIN. [Poster]
Web of Science

 

2014

Originalarbeit (Zeitschrift)

** Gattringer, T; Enzinger, C; Khalil, M; Schwingenschuh, P; Pichler, A; Moser, A; Graninger, W; Ernst, C; Haybaeck, J; Fazekas, F Unusual deterioration in a patient with multiple sclerosis on natalizumab therapy.
Neurol Neuroimmunol Neuroinflamm. 2014; 1(1):e1-e1 Doi: 10.1212/NXI.0000000000000001 [OPEN ACCESS]
PubMed FullText FullText_MUG

 

** Gnanapavan, S; Hegen, H; Khalil, M; Hemmer, B; Franciotta, D; Hughes, S; Hintzen, R; Jeromin, A; Havrdova, E; Tumani, H; Bertolotto, A; Comabella, M; Frederiksen, J; Álvarez-Cermeño, JC; Villar, L; Galimberti, D; Myhr, KM; Dujmovic, I; Fazekas, F; Ionete, C; Menge, T; Kuhle, J; Keir, G; Deisenhammer, F; Teunissen, C; Giovannoni, G Guidelines for uniform reporting of body fluid biomarker studies in neurologic disorders.
Neurology. 2014; 83(13):1210-1216 Doi: 10.1212/WNL.0000000000000809
Web of Science PubMed FullText FullText_MUG

 

** Hegen, H; Millonig, A; Bertolotto, A; Comabella, M; Giovanonni, G; Guger, M; Hoelzl, M; Khalil, M; Killestein, J; Lindberg, R; Malucchi, S; Mehling, M; Montalban, X; Polman, CH; Rudzki, D; Schautzer, F; Sellebjerg, F; Sørensen, PS; Deisenhammer, F Early detection of neutralizing antibodies to interferon-beta in multiple sclerosis patients: binding antibodies predict neutralizing antibody development.
Mult Scler. 2014; 20(5):577-587 Doi: 10.1177/1352458513503597
Web of Science PubMed FullText FullText_MUG

 

** Khalil, M; Riedlbauer, B; Langkammer, C; Enzinger, C; Ropele, S; Stojakovic, T; Scharnagl, H; Culea, V; Petzold, A; Teunissen, C; Archelos, JJ; Fuchs, S; Fazekas, F Cerebrospinal fluid transferrin levels are reduced in patients with early multiple sclerosis.
Mult Scler. 2014; 20(12):1569-1577 Doi: 10.1177/1352458514530020
Web of Science PubMed FullText FullText_MUG

 

** Pinter, D; Sumowski, J; DeLuca, J; Fazekas, F; Pichler, A; Khalil, M; Langkammer, C; Fuchs, S; Enzinger, C Higher education moderates the effect of T2 lesion load and third ventricle width on cognition in multiple sclerosis.
PLoS One. 2014; 9(1):e87567-e87567 Doi: 10.1371/journal.pone.0087567 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Ropele, S; Kilsdonk, ID; Wattjes, MP; Langkammer, C; de Graaf, WL; Frederiksen, JL; Larsson, HB; Yiannakas, M; Wheeler-Kingshott, CA; Enzinger, C; Khalil, M; Rocca, MA; Sprenger, T; Amann, M; Kappos, L; Filippi, M; Rovira, A; Ciccarelli, O; Barkhof, F; Fazekas, F Determinants of iron accumulation in deep grey matter of multiple sclerosis patients.
Mult Scler. 2014; 20(13):1692-1698 Doi: 10.1177/1352458514531085
Web of Science PubMed FullText FullText_MUG

 

Abstract (Zeitschrift)

** Enzinger, C (presented on behalf of Khalil M); Khalil, M; Langkammer, C; Pichler, A; Pinter, D; Mader, A; Bachmaier, G; Ropele, S; Fuchs, S; Fazekas, F; Dynamics of brain iron accumulation differ between clinically isolated syndrome and multiple sclerosis: a longitudinal 3T MRI study.
EUR J NEUROLOGY. EUROPEAN JOURNAL OF NEUROLOGY21: 58-58. HOBOKEN: WILEY-BLACKWELL; ( Presented at: Joint Congress of European Neurology, Istanbul, TURKEY, MAY 31-JUN 03, 2014) [Oral Communication]
Web of Science

 

** Hegen, H; Axtell, R; Hu, Y; Millonig, A; Bertolotto, A; Comabella, M; Giovanonni, G; Guger, M; Hoelzl, M; Khalil, M; Killestein, J; Lindberg, R; Malucchi, S; Mehling, M; Montalban, X; Rudzki, D; Schautzer, F; Sellebjerg, F; Sorensen, PS; Steinman, L; Deisenhammer, F Serum biomarkers predict IFNb treatment response in patients with multiple sclerosis
J NEUROL. 2014; 261: S43-S43.
Web of Science

 

** Hegen, H; Axtell, R; Hu, Y; Millonig, A; Bertolotto, A; Comabella, M; Giovanonni, G; Guger, M; Hoelzl, M; Khalil, M; Killestein, J; Lindberg, R; Malucchi, S; Mehling, M; Montalban, X; Rudzki, D; Schautzer, F; Sellebjerg, F; Sorensen, PS; Steinman, L; Deisenhammer, F; Serum biomarkers predict IFNb treatment response in patients with multiple sclerosis.
EUR J NEUROLOGY. 2014; 21: 57-57.-Joint Congress of European Neurology; MAY 31-JUN 03, 2014; Istanbul, TURKEY. [Poster]
Web of Science

 

** Khalil, M; Langkammer, C; Pichler, A; Pinter, D; Mader, A; Bachmaier, G; Ropele, S; Fuchs, S; Enzinger, C; Fazekas, F Dynamics of brain iron accumulation differ between clinically isolated syndrome and multiple sclerosis: a longitudinal 3T MRI study
J NEUROL. 2014; 261: S43-S43.-Joint Congress of European Neurology; MAY 31-JUN 03, 2014; Istanbul, TURKEY. [Oral Communication]
Web of Science

 

** Pichler, A; Khalil, M; Langkammer, C; Mader, A; Bachmaier, G; Ropele, S; Fuchs, S; Pinter, D; Enzinger, C; Fazekas, F Longitudinal changes of global and compartmental brain atrophy in patients with clinically isolated syndrome and clinically definite multiple sclerosis using 3-Tesla magnetic resonance imaging
J NEUROL. 2014; 261: S44-S44.-Joint Congress of European Neurology; MAY 31-JUN 03, 2014; Istanbul, TURKEY. [Oral Communication]
Web of Science

 

** Pichler, A; Khalil, M; Langkammer, C; Mader, A; Bachmaier, G; Ropele, S; Fuchs, S; Pinter, D; Enzinger, C; Fazekas, F; Longitudinal changes of global and compartmental brain atrophy in patients with clinically isolated syndrome and clinically definite multiple sclerosis using 3-Tesla magnetic resonance imaging.
EUR J NEUROLOGY. EUROPEAN JOURNAL OF NEUROLOGY21: 59-59. HOBOKEN: WILEY-BLACKWELL; ( Presented at: Joint Congress of European Neurology, Istanbul, TURKEY, MAY 31-JUN 03, 2014) [Oral Communication]
Web of Science

 

Abstract (Konferenzband)

** Khalil, M; Langkammer, C; Pichler, A; Pinter, D; Gattringer, T; Bachmaier, G; Ropele, S; Fuchs, S; Enzinger, C; Fazekas, F Dynamics of brain iron accumulation differ between clinically isolated syndrome and definite multiple sclerosis: a longitudinal 3T MRI study
Multiple Sclerosis Journal - 2014 Joint Actrims-Ectrims Meeting (MS Boston 2014). 2014; 20(S1):269-269.-MS Boston 2014 - Joint ACTRIMS-ECTRIMS Meeting; SEP 10-13, 2014; Boston, USA. [Poster]
Web of Science FullText

 

2013

Originalarbeit (Zeitschrift)

** Fazekas, C; Khalil, M; Enzinger, C; Matzer, F; Fuchs, S; Fazekas, F No impact of adult attachment and temperament on clinical variability in patients with clinically isolated syndrome and early multiple sclerosis.
Clin Neurol Neurosurg. 2013; 115(3):293-297 Doi: 10.1016/j.clineuro.2012.05.022
Web of Science PubMed FullText FullText_MUG

 

** Jehna, M; Langkammer, C; Khalil, M; Fuchs, S; Reishofer, G; Fazekas, F; Ebner, F; Enzinger, C An exploratory study on the spatial relationship between regional cortical volume changes and white matter integrity in multiple sclerosis.
Brain Connect. 2013; 3(3):255-264 Doi: 10.1089/brain.2012.0108
PubMed FullText FullText_MUG

 

** Khalil, M; Ebner, F; Fazekas, F; Enzinger, C Idiopathic hypertrophic cranial pachymeningitis: a rare but treatable cause of headache and facial pain.
J Neurol Neurosurg Psychiatry. 2013; 84(3):354-355 Doi: 10.1136/jnnp-2012-303295 (- Case Report)
Web of Science PubMed FullText FullText_MUG

 

** Khalil, M; Enzinger, C; Langkammer, C; Ropele, S; Mader, A; Trentini, A; Vane, ML; Wallner-Blazek, M; Bachmaier, G; Archelos, JJ; Koel-Simmelink, MJ; Blankenstein, MA; Fuchs, S; Fazekas, F; Teunissen, CE CSF neurofilament and N-acetylaspartate related brain changes in clinically isolated syndrome.
Mult Scler. 2013; 19(4):436-442 Doi: 10.1177/1352458512458010 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Langkammer, C; Liu, T; Khalil, M; Enzinger, C; Jehna, M; Fuchs, S; Fazekas, F; Wang, Y; Ropele, S Quantitative susceptibility mapping in multiple sclerosis.
Radiology. 2013; 267(2):551-559 Doi: 10.1148/radiol.12120707 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Pichler, A; Enzinger, C; Fuchs, S; Plecko-Startinig, B; Gruber-Sedlmayr, U; Linortner, P; Langkammer, C; Khalil, M; Ebner, F; Ropele, S; Fazekas, F Differences and similarities in the evolution of morphologic brain abnormalities between paediatric and adult-onset multiple sclerosis.
Mult Scler. 2013; 19(2):167-172 Doi: 10.1177/1352458512448107
Web of Science PubMed FullText FullText_MUG

 

** Teunissen, C; Menge, T; Altintas, A; Álvarez-Cermeño, JC; Bertolotto, A; Berven, FS; Brundin, L; Comabella, M; Degn, M; Deisenhammer, F; Fazekas, F; Franciotta, D; Frederiksen, JL; Galimberti, D; Gnanapavan, S; Hegen, H; Hemmer, B; Hintzen, R; Hughes, S; Iacobaeus, E; Kroksveen, AC; Kuhle, J; Richert, J; Tumani, H; Villar, LM; Drulovic, J; Dujmovic, I; Khalil, M; Bartos, A Consensus definitions and application guidelines for control groups in cerebrospinal fluid biomarker studies in multiple sclerosis.
Mult Scler. 2013; 19(13):1802-1809 Doi: 10.1177/1352458513488232
Web of Science PubMed FullText FullText_MUG

 

Abstract (Zeitschrift)

** Canto, E; Tintore, M; Costa, C; Arrambide, G; Villar, LM; Alvarez-Cermeno, JC; Deisenhammer, F; Hegen, H; Khademi, M; Olsson, T; Piehl, F; Bartos, A; Simova, D; Kotoucova, J; Kuhle, J; Kappos, L; Garcia-Merino, JA; Saiz, A; Blanco, Y; Hintzen, R; Jafari, N; Brassat, D; Tumani, H; Lauda, F; Roesler, R; Rejdak, K; Papuc, E; de Andres, C; Khalil, M; Galimberti, D; Scarpini, E; Montalban, X; Comabella, M Validation of cerebrospinal fluid chitinase 3-like 1 as a prognostic biomarker of conversion to multiple sclerosis and disease severity in patients with clinically isolated syndromes
MULT SCLER J. 2013; 19(11): 44-45. [Oral Communication]
Web of Science

 

** Hegen, H; Millonig, A; Bertolotto, A; Comabella, M; Giovanonni, G; Guger, M; Hoelzl, M; Khalil, M; Killestein, J; Lindberg, R; Malucchi, S; Mehling, M; Montalban, X; Polman, C; Rudzki, D; Schautzer, F; Sellebjerg, F; Sorensen, PS; Deisenhammer, F Early detection of neutralizing antibodies to interferon beta in multiple sclerosis patients
MULT SCLER J. 2013; 19(11): 294-295. [Poster]
Web of Science

 

** Khalil, M; Riedlbauer, B; Langkammer, C; Enzinger, C; Ropele, S; Stojakovic, T; Scharnagl, H; Culea, V; Petzold, A; Teunissen, C; Archelos, JJ; Fuchs, S; Fazekas, F Cerebrospinal fluid transferrin levels are reduced in patients with early multiple sclerosis
MULT SCLER J. 2013; 19(11): 545-545. [Poster]
Web of Science

 

** Kuhle, J; Dobson, R; Bestwick, JP; Topping, J; Dalla Costa, G; Khademi, M; Sombekke, M; Killestein, J; Evdoshenko, E; Lazareva, N; Runia, T; Zbornikova, P; Horakova, D; D'Alfonso, S; Thouvenot, E; Moll, N; Hegen, H; Rauch, S; Khalil, M; Fuchs, S; Lindberg, RLP; Derfuss, T; Llufriu, S; Franciotta, D; Roesler, R; Lauda, F; Rajda, C; Drulovic, J; Menge, T; Kieseier, BC; Avsar, T; Marignier, R; Malmestrom, C; Myhr, KM; Wergeland, S; Annibali, V; Romano, S; Carra, A; Laroni, A; Frederiksen, JL; Larsson, HB; Uccelli, A; Martinez, AD; Salvetti, M; Torkildsen, O; Lycke, J; Confavreux, C; Rejdak, K; Bosca, I; Brassat, D; Scarpini, E; Fenoglio, C; Galimberti, D; Siva, A; Hartung, HP; Dujmovic, I; Vecsei, L; Tumani, H; Bergamaschi, R; Colombo, E; Villoslada, P; Saiz, A; Enzinger, C; Kappos, L; Deisenhammer, F; Alvarez-Cermeno, JC; Villar, L; Pelletier, J; Lehmann, S; Castelnovo, G; Barizzone, N; Leone, M; Havrdova, E; Trojano, M; Iaffaldano, P; Direnzo, V; Comabella, M; Tintore, M; Montalban, X; Hintzen, R; Lapin, S; Teunissen, C; Piehl, F; Olsson, T; Furlan, R; Martinelli, V; Comi, G; Ramagopalan, S; Giovannoni, G Multivariate clinically isolated syndrome (CIS) risk factor study: towards individual prognosis and treatment indication in CIS
MULT SCLER J. 2013; 19(11): 33-34. [Oral Communication]
Web of Science

 

** Pinter, D; Sumowski, J; DeLuca, J; Fazekas, F; Pichler, A; Khalil, M; Langkammer, C; Fuchs, S; Enzinger, C Educational attainment moderates the effect of T2 lesion load and thalamic atrophy on cognition in multiple sclerosis
MULT SCLER J. 2013; 19(11): 437-438. [Poster]
Web of Science

 

2012

Originalarbeit (Zeitschrift)

** Schmied, MC; Zehetmayer, S; Reindl, M; Ehling, R; Bajer-Kornek, B; Leutmezer, F; Zebenholzer, K; Hotzy, C; Lichtner, P; Meitinger, T; Wichmann, HE; Illig, T; Gieger, C; Huber, K; Khalil, M; Fuchs, S; Schmidt, H; Auff, E; Kristoferitsch, W; Fazekas, F; Berger, T; Vass, K; Zimprich, A Replication study of multiple sclerosis (MS) susceptibility alleles and correlation of DNA-variants with disease features in a cohort of Austrian MS patients.
Neurogenetics. 2012; 13(2):181-187 Doi: 10.1007/s10048-012-0316-y
Web of Science PubMed FullText FullText_MUG

 

** Teunissen, CE; Khalil, M Neurofilaments as biomarkers in multiple sclerosis.
Mult Scler. 2012; 18(5):552-556 Doi: 10.1177/1352458512443092 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2011

Originalarbeit (Zeitschrift)

** Enzinger, C; Fuchs, S; Pichler, A; Wallner-Blazek, M; Khalil, M; Langkammer, C; Ropele, S; Fazekas, F Predicting the severity of relapsing-remitting MS: The contribution of cross-sectional and short-term follow-up MRI data.
Mult Scler. 2011; 17(6): 695-701. Doi: 10.1177/1352458510394454
Web of Science PubMed FullText FullText_MUG

 

** Jehna, M; Langkammer, C; Wallner-Blazek, M; Neuper, C; Loitfelder, M; Ropele, S; Fuchs, S; Khalil, M; Pluta-Fuerst, A; Fazekas, F; Enzinger, C Cognitively preserved MS patients demonstrate functional differences in processing neutral and emotional faces.
Brain Imaging Behav. 2011; 5(4): 241-251. Doi: 10.1007/s11682-011-9128-1
Web of Science PubMed FullText FullText_MUG

 

** Khalil, M; Enzinger, C; Langkammer, C; Petrovic, K; Loitfelder, M; Tscherner, M; Jehna, M; Bachmaier, G; Wallner-Blazek, M; Ropele, S; Schmidt, R; Fuchs, S; Fazekas, F Cognitive impairment in relation to MRI metrics in patients with clinically isolated syndrome.
Mult Scler. 2011; 17(2): 173-180. Doi: 10.1177/1352458510384009
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Khalil, M; Langkammer, C; Ropele, S; Petrovic, K; Wallner-Blazek, M; Loitfelder, M; Jehna, M; Bachmaier, G; Schmidt, R; Enzinger, C; Fuchs, S; Fazekas, F Determinants of brain iron in multiple sclerosis: a quantitative 3T MRI study.
Neurology. 2011; 77(18): 1691-1697. Doi: 10.1212/WNL.0b013e318236ef0e
Web of Science PubMed FullText FullText_MUG

 

** Khalil, M; Teunissen, C; Langkammer, C Iron and neurodegeneration in multiple sclerosis.
Mult Scler Int. 2011; 2011(3):606807-606807 Doi: 10.1155/2011/606807 [OPEN ACCESS]
PubMed FullText FullText_MUG

 

** Kincses, ZT; Ropele, S; Jenkinson, M; Khalil, M; Petrovic, K; Loitfelder, M; Langkammer, C; Aspeck, E; Wallner-Blazek, M; Fuchs, S; Jehna, M; Schmidt, R; Vécsei, L; Fazekas, F; Enzinger, C Lesion probability mapping to explain clinical deficits and cognitive performance in multiple sclerosis.
Mult Scler. 2011; 17(6): 681-689. Doi: 10.1177/1352458510391342
Web of Science PubMed FullText FullText_MUG

 

** Loitfelder, M; Fazekas, F; Petrovic, K; Fuchs, S; Ropele, S; Wallner-Blazek, M; Jehna, M; Aspeck, E; Khalil, M; Schmidt, R; Neuper, C; Enzinger, C Reorganization in cognitive networks with progression of multiple sclerosis: insights from fMRI.
Neurology. 2011; 76(6): 526-533. Doi: 10.1212/WNL.0b013e31820b75cf
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Ropele, S; de Graaf, W; Khalil, M; Wattjes, MP; Langkammer, C; Rocca, MA; Rovira, A; Palace, J; Barkhof, F; Filippi, M; Fazekas, F MRI assessment of iron deposition in multiple sclerosis.
J Magn Reson Imaging. 2011; 34(1): 13-21. Doi: 10.1002/jmri.22590 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Rovaris, M; Rocca, MA; Barkhof, F; Calabrese, M; De Stefano, N; Khalil, M; Fazekas, F; Fisniku, L; Gallo, P; Miller, DH; Montalban, X; Polman, C; Rovira, A; Sombekke, MH; Sormani, MP; Stromillo, ML; Filippi, M Relationship between brain MRI lesion load and short-term disease evolution in non-disabling MS: a large-scale, multicentre study.
Mult Scler. 2011; 17(3): 319-326. Doi: 10.1177/1352458510388824
Web of Science PubMed FullText FullText_MUG

 

** Teunissen, C; Koel-Simmelink, M; Pham, T; Knol, J; Khalil, M; Trentini, A; Killestein, J; Nielsen, J; Vrenken, H; Popescu, V; Dijkstra, C; Jimenez, C Identification of biomarkers for diagnosis and progression of MS by MALDI-TOF mass spectrometry.
Mult Scler. 2011; 17(7):838-850 Doi: 10.1177/1352458511399614
Web of Science PubMed FullText FullText_MUG

 

Abstract (Zeitschrift)

** Jehna, M; Langkammer, C; Wallner-Blazek, M; Neuper, C; Loitfelder, M; Fuchs, S; Khalil, M; Fazekas, F; Enzinger, C Cognitively preserved MS patients demonstrate functional differences in processing neutral and emotional faces
J NEUROL. 2011; 258: 154-154. [Poster]
Web of Science

 

2010

Originalarbeit (Zeitschrift)

** Mader, S; Lutterotti, A; Di Pauli, F; Kuenz, B; Schanda, K; Aboul-Enein, F; Khalil, M; Storch, MK; Jarius, S; Kristoferitsch, W; Berger, T; Reindl, M Patterns of Antibody Binding to Aquaporin-4 Isoforms in Neuromyelitis Optica
PLOS ONE. 2010; 5(5): e10455-e10455. Doi: 10.1371/journal.pone.0010455 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Abstract (Zeitschrift)

** Fazekas, C; Khalil, M; Enzinger, C; Fuchs, S; Fazekas, F Attachment style and temperament in people with early stages of multiple sclerosis
J PSYCHOSOM RES. 2010; 68(6): 47 [Poster]
Web of Science

 

2009

Originalarbeit (Zeitschrift)

** Khalil, M; Enzinger, C; Langkammer, C; Tscherner, M; Wallner-Blazek, M; Jehna, M; Ropele, S; Fuchs, S; Fazekas, F Quantitative assessment of brain iron by R(2)* relaxometry in patients with clinically isolated syndrome and relapsing-remitting multiple sclerosis.
Mult Scler. 2009; 15(9): 1048-1054. Doi: 10.1177/1352458509106609
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Abstract (Zeitschrift)

** Khalil, M; Enzinger, C; Langkammer, C; Petrovic, K; Loitelder, M; Tscherner, M; Jehna, M; Wallner-Blazek, M; Ropele, S; Schmidt, R; Fuchs, S; Fazekas, F The Spectrum of Cognitive Impairment and Its Relation to Brain Morphology Including Iron Deposition in Multiple Sclerosis.
NEUROLOGY. 2009; 72(11):A142-A142.-61st Annual Meeting of the American Academy of Neurology (AAN); APR 25-May 2, 2009; Seattle, USA. [Poster]
Web of Science

 

** Khalil, M; Enzinger, C; Langkammer, C; Petrovic, K; Loitfelder, M; Tscherner, M; Jehna, M; Wallner-Blazek, M; Ropele, S; Schmidt, R; Fuchs, S; Fazekas, F Cognitive impairment in patients with a clinically isolated syndrome - correlation with MRI parameters including magnetization transfer imaging.
MULT SCLER. 2009; 15(9):S227-S228.-25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS); SEP 9–12, 2009; Düsseldorf, GERMANY. [Poster]
Web of Science

 

** Khalil, M; Enzinger, C; Langkammer, C; Tscherner, M; Wallner-Blazek, M; Jehna, M; Ropele, S; Fuchs, S; Fazekas, F Quantitative Assessment of Brain Iron by R2(star) Relaxometry in Patients with Clinically Isolated Syndrome or Relapsing Remitting Multiple Sclerosis.
NEUROLOGY. 2009; 72(11):A435-A435.-61st Annual Meeting of the American Academy of Neurology (AAN); APR 25-May 2 2009; Seattle, USA. [Oral Communication]
Web of Science

 

2008

Fallbericht

** Khalil, M; Enzinger, C; Wallner-Blazek, M; Scarpatetti, M; Barth, A; Horn, S; Reiter, G Epstein-Barr virus encephalitis presenting with a tumor-like lesion in an immunosuppressed transplant recipient.
J Neurovirol. 2008; 14(6):574-578 Doi: 10.1080/13550280802345715 (- Case Report)
Web of Science PubMed FullText FullText_MUG

 

Abstract (Zeitschrift)

** Khalil, M; Enzinger, C; Petrovic, K; Loitfelder, M; Tscherner, M; Jehna. M; Wallner-Blazek, M; Ropele, S; Schmidt, R; Fuchs, S; Fazekas, F Executive dysfunction represents an underestimated component of cognitive impairment in multiple sclerosis.
Multiple Sclerosis2008; 14(S1):S258-S259.-World Congress on Treatment and Research in Multiple Sclerosis: ACTRIMS + ECTRIMS + LACTRIMS; SEPT 17-20, 2008; Montreal, CANADA. [Poster]
Web of Science

 

2006

Originalarbeit (Zeitschrift)

** Gneiss, C; Tripp, P; Ehling, R; Khalil, M; Lutterotti, A; Egg, R; Mayringer, I; Künz, B; Berger, T; Reindl, M; Deisenhammer, F Interferon-beta antibodies have a higher affinity in patients with neutralizing antibodies compared to patients with non-neutralizing antibodies.
J Neuroimmunol. 2006; 174(1-2): 174-179. Doi: 10.1016/j.jneuroim.2006.01.017
Web of Science PubMed FullText FullText_MUG

 

** Gneiss, C; Tripp, P; Reichartseder, F; Egg, R; Ehling, R; Lutterotti, A; Khalil, M; Kuenz, B; Mayringer, I; Reindl, M; Berger, T; Deisenhammer, F Differing immunogenic potentials of interferon beta preparations in multiple sclerosis patients.
Mult Scler. 2006; 12(6):731-737 Doi: 10.1177/1352458506070941
Web of Science PubMed FullText FullText_MUG

 

** Khalil, M; Reindl, M; Lutterotti, A; Kuenz, B; Ehling, R; Gneiss, C; Lackner, P; Deisenhammer, F; Berger, T Epitope specificity of serum antibodies directed against the extracellular domain of myelin oligodendrocyte glycoprotein: Influence of relapses and immunomodulatory treatments.
J Neuroimmunol. 2006; 174(1-2):147-156 Doi: 10.1016/j.jneuroim.2006.01.012
Web of Science PubMed FullText FullText_MUG

 

** Lutterotti, A; Kuenz, B; Gredler, V; Khalil, M; Ehling, R; Gneiss, C; Egg, R; Deisenhammer, F; Berger, T; Reindl, M Increased serum levels of soluble CD14 indicate stable multiple sclerosis.
J Neuroimmunol. 2006; 181(1-2):145-149 Doi: 10.1016/j.jneuroim.2006.09.002
Web of Science PubMed FullText FullText_MUG

 

Übersichtsarbeit

** Reindl, M; Khalil, M; Berger, T Antibodies as biological markers for pathophysiological processes in MS.
J Neuroimmunol. 2006; 180(1-2):50-62 Doi: 10.1016/j.jneuroim.2006.06.028
Web of Science PubMed FullText FullText_MUG

 

Abstract (Zeitschrift)

** Khalil, M; Kuenz, B; Lutterotti, A; Ehling, R; Gneiss, C; Egg, R; Mayringer, I; Deisenhammer, F; Reindl, M; Berger, T Levels of serum IgM antibody against refolded recombinant human MOG predict responsiveness to corticosteroids for treatment of acute multiple sclerosis relapses
J NEUROIMMUNOL. 2006; 178: 202-202. [Poster]
Web of Science

 

** Khalil, M; Zehrer, V; Egg, R; Lutterotti, A; Ehling, R; Gneiss, C; Mayringer, I; Kuenz, B; Reindl, M; Deisenhammer, F; Berger, T Interferon-beta in multiple sclerosis: ten years' experience in a multiple sclerosis specialist centre
MULT SCLER. 2006; 12: S195-S195. [Poster]
Web of Science

 

** Kuenz, B; Lutterotti, A; Ehling, R; Gneiss, C; Khalil, M; Deisenhammer, F; Berger, T; Reindl, M Characterisation of cell populations in cerebrospinal fluid of patients with multiple sclerosis
MULT SCLER. 2006; 12: S64-S64. [Poster]
Web of Science

 

** Lutterotti, A; Kuenz, B; Khalil, M; Gredler, V; Ehling, R; Gneiss, C; Deisenhammer, F; Berger, T; Reindl, M Serum levels of soluble CD14 correlate with disease activity in multiple sclerosis patients and are increased by interferon-beta treatment
MULT SCLER. 2006; 12: S66-S66. [Poster]
Web of Science

 

2005

Originalarbeit (Zeitschrift)

** Kuenz, B; Lutterotti, A; Khalil, M; Ehling, R; Gneiss, C; Deisenhammer, F; Reindl, M; Berger, T Plasma levels of soluble adhesion molecules sPECAM-1, sP-selectin and sE-selectin are associated with relapsing-remitting disease course of multiple sclerosis.
J Neuroimmunol. 2005; 167(1-2):143-149 Doi: 10.1016/j.jneuroim.2005.06.019
Web of Science PubMed FullText FullText_MUG

 

Abstract (Zeitschrift)

** Gneiss, C; Brugger, M; Reindl, M; Berger, T; Ehling, R; Lutterotti, A; Khalil, M; Kunz, B; Mayringer, I; Deisenhammer, F Comparative study of four different assays for the detection of binding antibodies against interferon-beta
MULT SCLER. 2005; 11: S159-S160.
Web of Science

 

** Khalil, M; Egg, R; Reindl, M; Lutterotti, A; Ehling, R; Gneiss, C; Kuenz, B; Deisenhammer, F; Berger, T Influence of immunomodulatory therapies on anti-myelin-antibodies in multiple sclerosis (MS)
J NEUROL SCI. 2005; 238: S225-S225.
Web of Science

 

** Khalil, M; Reindl, M; Lutterotti, A; Ehling, R; Gneiss, C; Kunz, B; Deisenhammer, F; Berger, T Impact of acute relapses and high-dose methylprednisolone therapy on serum anti-MOG antibodies in relapsing-remitting MS patients
MULT SCLER. 2005; 11: S169-S169.
Web of Science

 

** Kunz, B; Lutterotti, A; Ehling, R; Khalil, M; Reindl, M; Berger, T Increased plasma levels of soluble adhesion molecules sE-selectin, sPECAM-1 and sP-selectin are associated with relapsing-remitting disease course of multiple sclerosis
MULT SCLER. 2005; 11: S128-S128.
Web of Science

 

2004

Originalarbeit (Zeitschrift)

** Ehling, R; Lutterotti, A; Wanschitz, J; Khalil, M; Gneiss, C; Deisenhammer, F; Reindl, M; Berger, T Increased frequencies of serum antibodies to neurofilament light in patients with primary chronic progressive multiple sclerosis.
Mult Scler. 2004; 10(6):601-606 Doi: 10.1191/1352458504ms1100oa
Web of Science PubMed FullText FullText_MUG

 

** Gneiss, C; Reindl, M; Lutterotti, A; Ehling, R; Egg, R; Khalil, M; Berger, T; Deisenhammer, F Interferon-beta: the neutralizing antibody (NAb) titre predicts reversion to NAb negativity.
Mult Scler. 2004; 10(5):507-510 Doi: 10.1191/1352458504ms1074oa
Web of Science PubMed FullText FullText_MUG

 

Abstract (Zeitschrift)

** Khalil, M; Harrasser, M; Lutterotti, A; Ehling, R; Gneiss, C; Deisenhammer, F; Reindl, M; Berger, T The ability of anti MOG antibodies to fix the terminal complement complex differs among multiple sclerosis patients with different disease courses
MULT SCLER. 2004; 10(7032): S104-S104.
Web of Science

 

** Khalil, M; Reindl, M; Egg, R; Lutterotti, A; Ehling, R; Gneiss, C; Deisenhammer, E; Berger, T Influence of immunomodulatory therapies on anti-myelin antibodies in multiple sclerosis
MULT SCLER. 2004; 10(7032):S211-S212. [Poster]
Web of Science

 

** Khalil, M; Reindl, M; Lutterotti, A; Ehling, R; Gneiss, C; Deisenhammer, F; Berger, T Epitope specificity of antibodies directed against the extracellular domain of myelin oligodendrocyte glycoprotein (MOG-1g) during immunomodulatory therapies in multiple sclerosis patients
MULT SCLER. 2004; 10(7032): S165-S165.
Web of Science

 

** Lutterotti, A; Ehling, R; Lassmann, H; Khalil, M; Gneiss, C; Gassner, C; Deisenhammer, F; Berger, T; Reindl, M The CD14 C(-260)T promoter polymorphism influences disease severity in multiple sclerosis patients
MULT SCLER. 2004; 10(7032): S208-S208.
Web of Science

 

↑ Seitenanfang / Navigation

© Med Uni Graz • Impressum